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ABSTRACT 
 
Both humans and mice display an age-related decline in immunity.  Reduced 
generation of mature B cells may be a contributing factor due to reduced entry of mature 
B cells with novel B cell receptors and specificity for pathogens into the mature B cell 
pool.  In aged mice the numbers of B cell precursors within the bone marrow are 
diminished; there is a severe reduction in numbers of pre-B cells and an increase in 
numbers of re-circulated mature B cells.  Other defects in developing B cells include 
reduced expression of rag1 and rag2 when measured in total bone marrow precursor 
populations.  In the pro-B cell stage of development rag expression is essential to the 
process of V(D)J recombination and the generation of pre-B cells.  It was not known 
prior to this work if rag levels were lower in pro-B cells.  In Chapter 2 I show that rag2 
expression is reduced in pro-B cells of aged mice.  The reduction in rag2 expression is 
correlated with a loss of V(D)J recombinase activity in pro-B cells and reduced numbers 
of pre-B cells.  This suggests that in aged mice the reduction in rag2 expression is 
sufficient to result in reduced V(D)J recombinase activity and reduced generation of pre-
B cells, thus contributing to fewer pre-B cells in aged mice.  Furthermore, I have shown 
that the loss of rag2 expression and recombinase activity in pro-B cells are the result of 
age-associated defects in the bone marrow-microenvironment as opposed to cell-intrinsic 
defects in developing precursors. 
 
In Chapter 3 of this thesis I examine genetic influences on age-related defects in 
murine B cell development and correlations between bone marrow B cell subsets and 
peripheral T cell subsets.  It was known that longevity and age-related defects in T cell 
subsets are influenced by genetic differences between strains of inbred mice.  The impact 
of genetic polymorphisms on age-related defects in B cell development had not been 
previously assessed.  Nor was it known if these defects were correlated with age-related 
changes in peripheral T cell subsets.  Here I present evidence that B cell subsets in the 
bone marrow are influenced by genetic polymorphisms between mice strains.  Genetic 
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polymorphisms on Chromosomes 15 and 19 were found to influence the frequency of re-
circulated and pre-B cells in the bone marrow of aged mice.  Frequencies of bone marrow 
B cell subsets were compared with peripheral T cell subsets.  Interestingly, an association 
between the frequency of pre-B cells was not observed with either re-circulated B cells in 
the bone marrow nor peripheral T cell subsets.  However the frequency of pre-B cells was 
inversely correlated with the frequency of B220intIgM+ cells, a subset that was found to 
correlate with more advanced age-related T cell defects.  In addition, frequencies of re-
circulated B cells in the bone marrow were found to be associated with less advanced 
age-related defects in peripheral T cell subsets. 
 
These observations indicate that defects in B cell development, including reduced 
rag2 expression and V(D)J recombinase activity, are the result of changes in the aged 
murine bone marrow microenvironment.  In addition, a genetic polymorphism located on 
Chromosome 19 influences the frequency of pre-B cells in aged mice.  Furthermore the 
frequencies of B cell precursors in aged mice are not correlated with peripheral T cell 
subsets, but are correlated with frequencies of B220intIgM+ cells in the bone marrow.  
These observations advance our understanding of age-related defects in murine B cell 
development and may lead to identification of genes that influence B cell development in 
aged mice and humans as well as to help devise therapeutics aimed at restoring humoral 
immunity in aged individuals. 
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CHAPTER I 
 
Introduction 
 
1.1 Age-related changes in the human immune system 
With age, the human immune system is attenuated, resulting in increased 
susceptibility to pathogens and reduced tumor surveillance (1, 2). Vaccines have reduced 
efficacy in aged as compared to young individuals, memory responses do not last as long 
and there is reduced generation of high-affinity antibodies (2).  Vaccines to hepatitis and 
influenza both have reduced protective response in the elderly.  This immunosenescence 
is characterized by defects in both humoral and cellular immunity. 
 
Some of the humoral (B cell related) changes are reduced antibody diversity, class 
switching and affinity maturation.  Specific antibody titers in response to several vaccines 
are reduced in aged humans (1).  Antibody responses to tetanus toxin, influenza, 
encephalitis viruses, salmonella, and pneumococcus bacteria are all reduced with age (3).  
Another age-related change in humoral immunity is an increase in low-affinity auto-
reactive IgM antibodies in the serum (1, 2). 
 
The peripheral B cell pool provides the ability to respond to new and previous 
encountered pathogens.  This population is not static; cells are continuously removed and 
replaced by newly generated B cells throughout life.  This process provides a constant 
source of diverse immunoglobulin (Ig) that enables the host to respond to new pathogens.   
A reduction in B cell development would impair the ability of the peripheral pool to 
respond to novel antigenic threats due to diminished introduction of diverse Igs.  It has 
been suggested that in aged humans, generation of B cells in the bone marrow is greatly 
reduced (1).  However, as addressed in the discussion section (Chapter 4) studies to 
determine if B cell development is limited in aged humans are inconclusive.  
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Of the human age-associated changes in cellular immunity, one of the most noted is a 
reduction in cellularity and output of the thymus, the primary organ for T cell 
development (2).  In addition to reduced numbers, T cells in aged humans are also shifted 
from a naïve to memory phenotype.  There is also an increase in anergic T cells and a 
greater frequency of T cells with signal transduction defects (4) (5).  Proliferation and IL-
2 production by T cells from aged humans are reduced, limiting both activity of cytotoxic 
effectors and CD4+ T cell help for B cells (2).  These changes in T cell development and 
activation are thought to contribute to reduced tumor surveillance and increased 
incidence of cancer.  In addition, these changes contribute to reduced responses to 
pathogens and vaccines by both T cells and B cells as cytokines and direct cell contact 
with T helper cells is essential for B cell class switching and affinity maturation. 
 
1.2 Murine models to investigate immunity and aging 
Mice provide a useful model for the study of age-related changes in immunity.  One 
attractive feature of mice is that their lifespan is much shorter than humans and age-
related changes in immunity can be observed as early as 18 months of age.  In addition, 
inbred strains of mice can be used to study the effect of aging on a genetically consistent 
population. The use of inbred mice in controlled living environments also allows the 
study of age-related defects independent of variables in environment, diet, pathogenic 
exposure, genetics and other factors that can influence health.  Also, transgenic, knock-in, 
knock-out and mice with spontaneous gene mutations can be utilized to understand the 
impact of specific genes on age-related immune defects.  One particular mutant strain of 
mice, the Klotho mice, displays premature aspects of aging including reduced B cell 
development and numbers of mature peripheral B cells (6).  The number and frequency 
of pro-B cells and cells in further stages of B cell development are greatly reduced 
compared to wild-type mice.  The defect is not cell-intrinsic as hematopoietic stem cells 
do not display reduced capacity of B lymphopoiesis either in vivo following adoptive 
transfer to wild type mice or in vitro during culture on stromal cells established from 
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wild-type mice (6).  Thus the Klotho defect in B cell development is due to changes in 
the bone marrow microenvironment.   
 
Aging characteristics in the murine immune system are also being studied to 
determine if genetic differences between strains contributes to the onset and severity of 
age-related phenotypes. A Quantitative Trait Locus (QTL) analysis has been used to 
identify polymorphisms that influence longevity and age-associated changes in immune 
status in aged mice (7, 8).  In Chapter 3, I present and discuss results from a QTL 
analysis of B cell development in aged mice.   
 
1.3 Age-related changes in the murine immune system 
Like humans, mice display several age-associated changes in immune function, 
including reduced B and T cell generation (2, 9) and increased susceptibility to pathogens 
(e.g. influenza) (10). 
 
Many of the T cell-specific alterations seen in humans also occur in mice.  As in 
humans, the murine thymus undergoes involution with age.  In addition, the percentage of 
T cells that are of the memory phenotype increases with age (2).  Increased frequency of 
T cells with signaling defects (11, 12) and reduced cytokine production (2) by T cells 
from aged mice may contribute to reduced B cell activation and antibody response to 
vaccines and pathogens. TCR repertoire diversity is reduced in aged mice. CD8+ T cells 
express a wide range of TCR V regions is in young mice, however in aged mice there is 
restricted utilization of V gene segments with over-representation of some Vs 
(indicating expansion of T cell clones) (13). 
 
Several of the human age-associated defects in B cells are also observed in mice.  
This includes reduced generation of high-affinity antibodies in response to vaccination 
and infection (10), and loss of hypermutation, affinity maturation and germinal center 
formation  (14).  In addition, different VH gene segments are used in aged as compared to 
 14 
young mice in response to specific antigens (2, 15).  In aged mice, the number of mature 
peripheral B cells is similar to that of young mice, however, the rate of turn-over is lower 
as fewer mature B cells are generated (9).  The age-associated decline in humoral 
immunity may be partially due to reduced B cell receptor diversity and increased clonal 
expansion of limited numbers of B cells.  These in turn could be the result of reduced 
generation of B cells in aged mice. 
 
1.4 Murine B cell development 
B cell development occurs continuously during life.  In adult mice, this process 
occurs in the bone marrow and proceeds through an ordered series of developmental 
stages, concluding predominantly in the spleen.  In the earliest stages, Multi-potent 
Progenitors (MPPs) undergo commitment to the lymphoid lineage(s) and become 
Common Lymphoid Progenitors (CLP) that can develop into B or T lymphocytes, 
Natural Killer (NK) cells or dendritic cells (16, 17).  CLPs that commit to the B lineage 
then progress through stages of pro-B, pre-B and immature B cells in the bone marrow, 
and are then exported to the spleen where they progress through stages of immature 
transitional B cells and develop into mature naïve B cells.  
 
Stages of B cell development are defined by acquired characteristics, such as the 
expression of lineage-specific genes and cell surface antigens (18).  Differences in 
surface antigen expression define the B cell developmental pathway. Developing B cells 
are divided into pro-B (IgM-B220+CD43+), pre-B (IgM-B220+CD43-) and immature 
(IgM+B220LOCD43-) stages in the bone marrow.  Pro-B cells can be further divided into 
developmental Fractions (Fr.) A, B and C based on expression of CD24 (Heat Stable 
Antigen or HSA) and BP-1 (18).
FIGURE 1.  Murine B  Cell  Development
Imm. B
Hardy Fraction
A             B              C
pre-B Imm. B mature B
B220+CD43+
IgM- AA4.1+
Bone marrow Spleen
B220+CD43-
IgM- AA4.1+
B220+CD43-
IgM+ AA4.1+
pro-B
B220+CD43-
IgM+ AA4.1+/-
IgD-
B220++CD43+
IgM- AA4.1-
IgD+
CD24-
BP-1-
CD24+
BP-1+
CD24+
BP-1-
DH JH
VH DJH
VL JL
FIGURE 1.  Murine B cell development.  The schematic displays stages of B cell 
development in the bone marrow and spleen.  Stage defining surface markers are 
displayed at the top.  Recombination events are displayed at the bottom.
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1.5 V(D)J recombination assembles complete Ig variable region genes during B cell 
development. 
The variable regions of Ig genes are encoded by multiple Variable (V), Diversity 
(D), and Joining (J) gene segments located upstream of Ig Constant (C) regions.  In mice 
there are 134 VH, 13 DH and 4 JH gene segments in the immunoglobulin heavy chain 
(IgH) locus and 85 V and 5 J gene segments and 3 V and 4 J functional gene 
segments in the IgL chain loci (19). These gene segments are somatically rearranged to 
from functional Ig genes during B cell development by the process of V(D)J 
recombination (20, 21).  In each B cell progenitor, a unique combination of VH, DH and 
JH gene segments (one of each segment) are joined together to encode the IgH variable 
region, and one VL and one JL gene segment are joined to encode the IgL variable region.  
Each V, D, and J segment is flanked by conserved recombination signal sequence (RSS).  
The RSSs are evolutionary conserved sequences of DNA composed of heptamer and 
nonamer sequences that are generally conserved in content and are separated by either 12 
or 23 base pair spacer (20, 21).  The size of the RSS spacer mediates one level of 
regulation during V(D)J recombination; recombination events only occur between gene 
segments flanked by RSSs of different sizes, this is referred to as 12/23 rule. 
 
Expression of Recombinase Activating Genes, rag1 and rag2 are essential to V(D)J 
recombination. rag1 and rag2 are coordinately expressed during B and T cell 
development (22-24).  During V(D)J recombination, RAG1 and RAG2 bind to RSSs and  
assemble a synaptic complex with two Ig gene segments.  Following formation of the 
complex, RAG1 and RAG2 introduce DNA double-strand breaks between the RSS and 
the flanking gene segment (25, 26).  The DNA ends generated by RAG1 and RAG2 are 
referred to as the coding end for the segment containing the encoded Ig or TCR gene, and 
the signal end for the segment containing the RSS.  After further coding end processing, 
the DNA breaks are repaired by non-homologous end joining to complete the 
recombination reaction.  This requires activity of several ubiquitously expressed DNA 
double-strand break repair proteins: Ku70, Ku80, DNA-PK, XRCC4, DNA Ligase IV, 
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and Artemis.  The two coding ends are ligated to form a coding joint, and the two signal 
ends are ligated to form a signal joint.  In most Ig or TCR recombination events, the 
signal joint results in formation of circular piece of DNA containing the region that was 
originally between the two ligated gene segments, and this extra-chromosomal DNA is 
not replicated with cell divisions.  As a result of V(D)J recombination, the coding joint 
now connects two gene segments that encode part of a new antigen receptor. 
 
IgH and IgL genes are assembled during B cell development.  During the pro-B cell 
stage of development, two recombination events in the IgH locus produce a rearranged, 
intact IgH variable region gene.  First DH to JH recombination occurs, followed by VH to 
DHJH recombination.  During the pre-B cell stage, a light chain gene is formed by one 
recombination event; V to J recombination of either V to J or V to J.  Expression of 
rag1 and rag2 are up-regulated in the pro-B cell stage, when the IgH gene is assembled, 
and are again up-regulated in the pre-B cell stage when Ig light (IgL) chain gene is 
rearranged (22-24, 27).  Regulation of rag expression during B cell development is 
discussed further below. 
 
1.6 The pre-BCR checkpoint regulates B cell development. 
Transit between the pro- and pre-B cell stages is regulated by signaling though the 
pre-B cell Receptor (pre-BCR).  In the absence of pre-BCR signaling, cells fail to 
progress to the pre-B cell stage of development.  The pre-BCR is composed of Ig and 
Ig, the IgH chain and the surrogate light chain that is composed of 5 and Vpre-B.  
Signaling through the pre-BCR is dependent upon the presence of a functional rearranged 
IgH gene.  Production of functional IgH requires that following the recombination events, 
the variable region and constant region are in the same frame such that a protein can be 
correctly translated and that the protein can fold appropriately and associate with the 
surrogate light chain and Ig and Ig.  If the VH to DJH joining on one allele does not 
produce a functional Ig heavy chain, pre-BCR signaling and progression to the pre-B cell 
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stage does not occur, thus providing time for VH to DJH recombination on the other allele.  
If neither allele produces a functional heavy chain the pro-B cell undergoes apoptosis. 
 
If a functional heavy chain is made, signals through the pre-BCR result in 
developmental changes in the precursor cell.  Expression of rag1 and rag2 is turned off 
and the cell undergoes several rounds of proliferation.  This accelerates the degradation 
of RAG1 and RAG2, as RAG2 is phosphorylated during the cell cycle resulting in 
ubiquitin-dependent degradation (21) and RAG1 half-life is shortened when not 
associated with RAG2 (21).  This stops further recombination of IgH thus preventing 
rearrangement and expression of two IgH chains (a phenomenon known as allelic 
exclusion).  In addition proliferation expands the number of precursors, resulting in 
greater numbers of pre-B cells than pro-B cells (3:1 ratio) in young mice. 
 
Signaling through the pre-BCR induces several signaling pathways and changes gene 
expression in developing precursors.  Ig and Ig both contain immunoreceptor tyrosine-
based activation motifs (ITAMs) that are phosphorylated upon pre-BCR assembly and 
provide sites for interaction with Syk tyrosine kinase (28).  The adaptor protein BLNK 
(SLP-65, BASH)  is phosphorylated at multiple N-terminal tyrosines upon interaction 
with Syk (29).  BLNK then links pre-BCR signaling to several downstream signaling 
pathways by providing docking sites in the pre-BCR signal complex for SH2 domain-
containing proteins that include PLC2, Btk, Vav and Nck (29).  Mutations in BLNK 
result in a block in B cell development at the pro- to pre-B cell transition in both humans 
(30) and mice (31, 32). 
 
Btk (Bruton’s tyrosine kinase), a member of the Tec family of cytoplasmic protein 
kinases, transduces signals from the pre-BCR (33) (and the BCR).  Humans with 
mutations in btk have an almost complete arrest in B cell development at the pre-B cell 
stage and an almost complete absence of mature B cells and circulating antibodies (34-
36).  Pre-B cell numbers are reduced in xid mice (mice in which the BTK gene is 
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defective) and btk knock-out mice as a result of reduced transition of cell from the pro- to 
pre-B cell stage of development (37-39).  In addition, compared to wild-type mice, large-
cycling pre-B cells from btk-deficient mice displayed enhanced proliferation and reduced 
progression into CD2+CD25+ surrogate light- small pre-B cells (37).  BLNK also recruits 
Vav and Nck, both of which are important in cytoskeleton remodeling (40).  Src-family 
tyrosine kinases (Blk, Fyn, Lyn) are also activated by pre-BCR signaling resulting in 
activation of NF-B which promotes cell survival (40, 41).  Gene expression assays have 
shown that pre-BCR signaling results in activation of 56 genes and repression of 34 genes 
(42). 
 
As mentioned above, the pro- to pre-B cell checkpoint is dependent upon signaling 
through the pre-BCR.  Defects in any of the pre-BCR components result in a lack of 
signaling and progression to the pre-B cell stage.  For example, in the absence of a 
functional IgH chain, pre-BCR signaling does not occur and pro-B cells fail to progress 
to the pre-B cell stage.  Expression of both rag1 and rag2 are essential to V(D)J 
recombination; therefore, in their absence an intact IgH chain is not produced and B cell 
development is blocked at the Fr. B/C pro-B cell stage (43, 44). 
 
1.7 Murine B cell development is dependent upon factors from microenvironment. 
Contact-mediated signals from bone marrow stromal cells and soluble factors are 
required for commitment, development, proliferation and survival of developing B cell 
precursors. Some of these effects are mediated by transcription factors that govern gene 
expression while some produce more direct changes through the activation of specific 
proteins.  Pro-B cells are dependent upon direct contact with stromal cells while pre-B 
cells require soluble factors in the bone marrow environment. 
 
IL-7 is produced by stromal cells and is essential for proliferation and differentiation 
of B cell progenitors in vivo (45, 46). The IL-7 receptor (IL-7R) is heterodimeric, 
composed of IL-7 and the c chain which is utilized by IL-2, IL-4, IL-7, IL-9 and IL-15 
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(46, 47). IL-7 is first expressed in CLPs (16).  Signaling through IL-7R is necessary for 
commitment to the B cell lineage as: 1) when cultured on stromal cells with IL-7, CLPs 
differentiate into B lineage precursors; 2) when CLPs were cultured in fetal thymic organ 
culture supplemented with IL-7 for 4 days they were unable to give rise to T cell 
precursors following intrathymic transfer, and 3) IL-7R-/- mice have normal frequencies 
of CLPs but a block in production of pre-pro-B cells and further B cell development in 
the bone marrow (48).  In addition to lineage commitment in CLPs, signaling via the IL-
7R during the pro-B cells stage of development results in hyperacetylation of histones in 
the 5’ VH regions (this is thought to result in accessibility to the V(D)J recombinase 
[discussed below]) (49).  IL-7R signaling also results in proliferation and survival of pro-
B cells.   
 
The stromal cell product Stromal Derived Factor (SDF-1), also known as CXCL12, 
is a chemokine produced by bone marrow stromal cells that is essential for retaining B 
cell precursors in the bone marrow (50, 51).  Incubation of B cell lines with SDF-1 results 
in activation of Rap1 and Rap2, Ras superfamily GTPases thought to regulate cell 
migration (52).  Blocking activation of Rap1 and Rap2 results in decreased ability of B 
cell lines to migrate towards medium containing SDF-1 in a transwell assay (52).  During 
B cell development interaction between SDF-1 and the receptor CXCR4 are important at 
the Lin-CD19-c-kit+IL-7R +AA4.1+ stage of fetal B cell development (53).  Deletion of 
either SDF-1 or CXCR4 is embryonic lethal and these mice have very few pro-B cells in 
fetal liver at day 18 (54).  Signaling through CXCR4 in pre-B cells results in proliferation 
of pre-B cells (54). 
  
Another receptor/ligand pair that is critical for B cell development is fms-like 
tyrosine kinase-3 (flt3 or flk2) and FL (flt3 ligand). Flt3 is expressed in developing 
precursors through the pre-B cell stage of development (55).  FL deficient mice have 
reduced numbers of CLPs (56) and flk2-/- mice have reduced numbers of pro-B cells 
(57).  FL and IL-7 are sufficient and required for stromal-independent in vitro B cell 
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development from multi-potent hematopoietic progenitors (58) and FL-/-IL-7R-/- double 
deficient mice completely lack conventional IgM+ B cells (59). 
 
Signals from the bone marrow microenvironment result in activation of transcription 
factors at different stages of B cell development.  In turn, transcription factors activate 
and suppress genes that establish and enforce lineage commitment, promote survival, 
proliferation and development. 
 
1.8 Murine B cell development is regulated by transcription factors. 
Graded expression of the transcription factor PU.1 (a member of the ets protein 
family) in multi-potential progenitors regulates commitment to the myloid, dendritic, and 
B lineages (60, 61).  Low-level expression of PU.1 promotes B cell development (60, 
61).  In the absence of PU.1, development of T lineage cells but not B or myeloid cells 
can occur (41, 61).  The ability of PU.1 to direct B lineage commitment, development 
and proliferation is through the regulation of IL-7R transcription (62).  IL-7R 
signaling is essential for commitment of progenitors to the B lineage (48).  Retroviral 
transduction of IL-7R into PU.1-/- progenitors restores proliferation in response to 
stromal cells and IL-7 and results in a low frequency of precursors that develop into 
CD19 pro-B cells that express mb-1 (encodes Ig), B29 (encodes Ig), VpreB, 5, EBF 
and pax5 (62).  This does not indicate that PU.1 activates these genes, rather that PU.1 
through expression of IL-7R supports proliferation and differentiation to the pro-B stage 
of development where transcription factors E2A, pax5 and EBF are expressed. 
 
Pax5 (BSAP or B cell-Specific Activator Protein), E2A and EBF (Early B Cell 
Factor) are transcription factors whose function is essential in precursors committed to 
the B lineage (63).  Pax5 maintains B lineage commitment by suppressing expression of 
NOTCH, which can promote T cell development over B cell development (41).  
Following experimentally-induced loss of pax5, pro-B cells can revert to macrophages 
and T cells (64). pax5 regulates expression of genes required for B cell development, 
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including blnk (SLP-65) and CD19. pax5 may be regulated by E2A and EBF (discussed 
below), and in conjunction these three factors appear to regulate expression of mb-1 
(encodes Ig), B29 (encodes Ig), VpreB,   (41, 61).  pax5-deficient mice have an 
essentially complete block in B cell development at the pro-B cell stage (at Hardy Fr. B) 
and while cells have DJH junctions, V to DJH are almost undetectable (65-67). 
 
E2A and EBF (Early B Cell Factor) also regulate B cell development by activating B 
cell-specific genes.  E2A encodes proteins E12 and E47, which are critical for B cell 
development.  Mice lacking E2A have a block in B cell development prior to Ig gene 
rearrangement (41, 68-70).  E47 was recently found to bind conserved E-boxes in a 
regulatory element for RAG expression (ERAG) (explained below) (71).  Ectopic 
expression of E12 up-regulates expression of EBF (69).  Deletion of EBF results in 
arrested B cell development prior to Ig gene rearrangement and a lack of Pax5 expression 
(63).  Binding sites for EBF have been detected in 5, VpreB, and Ig (63) and EBF may 
regulate pax5 (69).  Together E2A, EBF and pax5 control transcription of the early B cell 
genes mb-1 (encodes Ig), B29 (encodes Ig), VpreB, and 5 (41, 61).  E2A and EBF 
also regulate accessibility of the recombinase to the Ig loci as transfection of E2A, EBF, 
rag1 and rag2 into non-lymphoid cells results in V(D)J rearrangement (72, 73).  
Overexpression of E2A, rag1 and rag2 in a human cell line resulted in Ig V1J but not Ig 
recombination.  Expression of EBF, rag1 and rag2 resulted in VIII-J1 recombination.  
When E2A, EBF, rag1 and rag2 were expressed together, DH4J recombination occurred 
but VH to DJH was not observed (72, 73). 
 
There are two requirements for V(D)J recombination:  accessibility of Ig gene 
segments for recombination and the enzymatic activity of the V(D)J recombinase.  Both 
accessibility and recombinase activity are developmentally regulated  
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1.9 Expression of rag1 and rag2 are developmentally regulated. 
Highly conserved core promoters and cis-elements control transcriptional regulation 
of rag1 and rag2. rag1 and rag2 are located in one locus in the genome of all animals 
studied and are convergently transcribed (21, 74).  The murine and human promoters for 
both rag1 and rag2 are highly conserved (75).  rag1 and rag2 are the only essential 
lymphoid-specific components of the V(D)J recombinase and their expression is tissue 
and developmental stage-specific.  While murine and human rag1 expression can be 
observed in non-lymphoid cell types, rag2 expression is lymphoid specific and 
differentially regulated in B and T cells (75).  pax5 is expressed in B but not T cells (76) 
and binds to a conserved sequence essential to expression of rag2  (75).  Myb is 
expressed in developing T but not B cells (77, 78), binds the rag2 promoter and is critical 
for rag2 promoter activity in T cells (79). 
 
In addition to core promoters, cis-acting elements 5’ of rag2 are essential to 
expression of both rag1 and rag2 and contribute to differential regulation in B and T cells 
(80, 81).  The ERAG element located 22 kb 5’ of rag2 has 90% DNA sequence homology 
between mice and humans and is essential to rag1 and rag2 expression in B but not T 
lineage cells (71).  ERAG-/- mice have 3-fold fewer pre-B cells and reduced numbers of 
mature splenic B cells compared to wild type mice.  In ERAG-/- mice transcription of 
rag1 and rag2 are reduced in pro-B cells (5-15 fold and 2-3 fold), as is frequency of 
dsDNA breaks associated with V to DJH joining (71).  Recent work has shown that the 
V(D)J recombinase is active in the common lymphoid progenitor (CLP) and is largely 
controlled by the ERAG enhancer in the B lineage.  This observation supports the concept 
that a B lineage-specific transcription program is already established in the CLP (82).  
E2A binds ERAG in pro-B cells as shown by chromatin immunoprecipitation (ChIP) 
assay and transfection of E2A into 293T cells induces expression of rag1 and rag2 (71).  
It is thought that additional uncharacterized cis-acting elements exist upstream of rag2 as 
there are approximately 20 non-coding sequences of 200 bp or more that lack significant 
ORFs and have 80% homology between mouse and human (21). 
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1.10 Regulation of accessibility to Ig gene segments 
The same recombinase rearranges both Ig and TCR gene segments; however, 
recombination events occur in a tissue and stage-specific manner.  IgH chains are only 
completely recombined in pro-B, IgL ( and ) in pre-B, TCR in pro-T and (most) 
TCR in pre-T cells).  It has been proposed that selective rearrangement of Ig loci is 
governed by accessibility of the recombinase to Ig gene segments (83).  This model is 
supported by the observation that in in vitro assays, RSSs in DNA harvested from non-
lymphoid cells are inaccessible to RAG-mediated cleavage; however chromatin from 
lymphocytes is accessible in a pattern that matches Ig recombination in the cell type from 
which it was purified (21). 
 
Regulation of Ig gene segment accessibility is not fully understood and may be 
linked to transcriptional accessibility.  The transcriptional promoters and enhancers are 
required for efficient cleavage by the recombinase (21).  Signaling through the pre-BCR 
results in binding of transcription factors to the Ig enhancer and activation of germ-line 
Ig transcription (21).  V to J rearrangements is absent in mice in which the two  locus 
enhancers have been deleted (20, 84). Deletion of the T early  promoter (TEA) (located 
5’ of the J segments) results in reduced rearrangements of the most 5’ J segments 
located 15 kb downstream of the promoter (20, 85).  It is thought that promoters and 
enhancers allow accessibility to DNA in a localized manner; however there are examples 
of transcribed Ig gene segments that do not undergo V(D)J recombination and examples 
of V(D)J recombination in the absence of germ-line transcription (20). 
 
We are just beginning to understand how accessibility of Ig gene segments for 
transcription or recombinase activity is regulated by DNA methylation, histone 
modification and nuclear localization (21). Methylation of CpG islands leads to gene 
inactivity, and less susceptibility to recombinase cleavage (20, 21).  Demethlylation of 
the Ig locus correlates with active recombinase (20, 21). 
 
 25 
Accessible DNA is characterized by hyper-acetylated lysine residues in the N-
terminus of histones H3 and H4 (20).  The histones associated with the VH region in pro-
B cells undergo histone acetylation after IL-7 stimulation (86).  This acetylation of VH 
regions occurs prior to VH to DJH recombination (86, 87).  Expression of transmembrane 
mu in the pre-BCR results in de-acetylation of the VH locus and increased acetylation of 
the  locus (87).  It was also observed that the chromatin including the Ig gene segments 
in the IgH locus are acetylated but the intervening stretches of DNA are not, indicating a 
specific regulatory mechanism that specifically provides access to gene segments (87).  
Further evidence of the role of histone acetylation in control of V(D)J recombinase 
accessibility comes from recent investigation of the role of Ezh2.  Deletion of Ezh2, a 
factor known to regulate chromatin structure, resulted in lower histone methylation of 5’ 
VH gene segments (specifically the J558 family) in pro-B cells following incubation with 
IL-7 (88).  In addition, pro-B cells from Ezh2-/- mice have diminished V to DJH 
rearrangement and reduced number and frequency of pre- and immature B cells (21, 88).  
Nuclear localization of gene segments also contributes to regulation of recombinase 
accessibility.  Transcribed and non-transcribed regions of DNA are located in different 
domains of the nucleus.  In non-lymphoid cells and T cells, the IgH alleles are located in 
peripheral nuclear areas; however in pro-B cells they were localized in central nuclear 
area (89). 
 
1.11 B cell development is attenuated in aged mice. 
Frequencies of B cell subsets in the bone marrow and B cell generation undergo age-
associated changes in mice.  In aged mice B cell generation is markedly reduced (9, 90).  
Fewer mature B cells are produced but the number of mature B cells is similar to that of 
young mice due to a significant increase in the half-life of mature cells (1, 9).  
Frequencies and numbers of B cell subsets in the bone marrow also change with age.  
The most noted change is the reduced frequency and number of pre-B cells.  The extent 
of reduction, and age at which this occurs varies between reports (90-95).  Initial reports 
indicated that numbers of pro-B are not reduced in aged mice.  However, our results 
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(Chapter 2), along with two recent reports indicate that numbers of pro-B cells are 
significantly reduced in aged mice (48, 91). This apparent discrepancy is addressed in 
Chapter 2.   In addition, the number of mature re-circulated B cells in the bone marrow 
increases in aged mice (9, 91). 
 
The onset and severity of reduced pre-B cell numbers can vary substantially between 
mice, even of the same age, strain, gender and environmental conditions.  Mice with 
more extensive loss of pre-B cells tend to have reduced numbers of pro-B cells while 
mice with moderate reductions in pre-B cells tend to have numbers of pro-B cells that are 
slightly reduced, or similar, to that seen in young mice (91).  Numbers of mature re-
circulated B cells in the bone marrow of aged mice are higher in mice with moderate 
reduction in numbers of pre-B cells, but are reduced in mice with severe reductions in 
numbers of pre-B cells (91).  These defects may be due to one underlying mechanism that 
affects B cell development at more than one stage or due to multiple distinct changes that 
occur with age. 
 
1.12 Is pre-B cell generation reduced in aged mice? 
A primary goal of this thesis is to understand mechanism(s) that contribute to the 
reduction in numbers of pre-B cells in aged mice.  Some potential mechanisms include: 
1) increased apoptosis of pre-B cells, 2) reduced transit times of pre-B cells to the 
immature B cell compartment, and 3) reduced generation of pre-B cells.  It is formally 
possible that each mechanism contributes to the reduced numbers of pre-B cells. 
 
Reduced generation of pre-B cells is supported by the observation that development 
within pro-B cells is impaired in aged mice.  Two recent papers and my data in Chapter 2 
find a reduction in numbers of cells in more mature pro-B cell stages (91, 95, 96).  In 
addition, rag1 and rag2 mRNA levels decline dramatically when measured in the total 
bone marrow of aged mice (3, 97, 98).  RAG1 and RAG2 are essential to the generation 
of pre-B cells.  This reduction in expression of rag1 and rag2 could suggest attenuated 
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pre-B cell generation in aged mice.  This idea is one of the central hypotheses of this 
thesis: that in aged mice reduced rag expression in pro-B cells results in reduced V(D)J 
recombinase activity and in turn, reduced generation of pre-B cells.  While decreased 
levels of rag expression within the bone marrow of aged mice was previously 
demonstrated (97, 99), the effect of age on rag1 and rag2 expression within pro-B cells 
had not been directly demonstrated before this work.  In addition, it was not known if the 
age-related decline in rag expression is due to a global loss of bone marrow cellularity 
independent of regulation of rag expression, a decrease in the number of specific cells 
that express rag or a decline in the per cell level of rag expression within pro-B cells.  
BRDU labeling experiments have shown that generation of pre-B cells is reduced in aged 
mice as compared to younger mice and that the transit time for pre-B cells is similar in 
aged vs. young mice (Dr. M. Cancro, UPENN, personal communication; addressed in 
Chapter 4 Discussion.) 
 
Another possible mechanism that would contribute to reduced numbers of pre-B 
cells is decreased signaling through the pre-BCR due to reduced expression of 5 (95).  
5 is a component of the pre-BCR that is essential for developmental progression to the 
pro-B cell stage.  Expression of surface and cytoplasmic 5 is reduced in pro-B cells of 
aged mice (95). 
 
1.13 Microenvironment or cellular defects underlie reduced B cell development with 
age. 
The decrease in numbers of pre-B cells in aged mice could be due to either cell-
intrinsic defects in the B cell precursors themselves or alterations in the developmental 
microenvironment. The bone marrow microenvironment is thought to provide essential 
signals for stimulating expression of rag during B cell development: however, 
environmental and cell-intrinsic causes for reduced numbers of pre-B cells in aged mice 
had not been addressed prior to this work. 
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Pre-B cell numbers decline with age, and thymic involution progresses with age.  It 
has been proposed that reduced thymic output affects the bone marrow microenvironment 
and contributes to reduced numbers of pre-B cells in aged mice (98).  This is supported 
by the observation that numbers of pre-B cells and expression of both rag1 and rag2 are 
lower in young athymic mice as compared to young wild-type mice (97, 98).  In addition, 
injection of T cells or supernatant from cultures of activated T cells into nude mice 
resulted in increased expression of rag1 and rag2 in bone marrow of athymic mice (97, 
98).  These observations have led to the hypothesis that rag1 and rag2 expression in 
developing B cells is influenced by T cell factors, which are absent in nude mice and 
decline with thymic involution during aging.  Additional support for the hypothesis that 
the decline in B cell development with age is due to defects in the microenvironment 
comes from stromal cell culture experiments.  Stromal cell cultures established from aged 
mice are less supportive of proliferation and development of pro-B cells than cultures 
established from younger mice (94).  IL-7 is critical for B cell development.  When an 
IL-7-dependent cell line was cultured on stromal cells from young and aged mice, the 
percent of cells in cell cycle was higher in stromal cultures established from young mice 
at 25, 50 and 75 hours (93).  This indicates that availability of IL-7 may be limited in 
stromal cells from aged mice.  
 
Reduced response to IL-7 could also be due to cell-intrinsic defects in precursors 
from aged mice. Pro-B cells from aged mice proliferate to a lesser extent than pro-B cells 
from young mice when cultured in vitro with IL-7 (93, 96, 100).  Interestingly, 
expression of IL-7R is similar between precursors from young and aged mice (94, 96, 
101).   This could indicate that intrinsic signaling in response to IL-7 is defective in B cell 
precursors in aged mice.  Most of the evidence supporting cell-intrinsic, age-related 
defects is from in vitro experiments.  It is possible that the cellular defects observed in 
culture are due to changes that are “imprinted” on developing B cells by changes in the in 
vivo microenvironment. Developing cells may go through stages where lack of exposure 
to various stimuli results in developmental arrest that the cells cannot recover from.  This 
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could result in the presence of pro-B cells that have impaired function but have not yet 
been removed from the bone marrow by apoptosis.  Another important goal of this thesis 
work was to determine if age-related loss of pre-B cells and reduced expression of rag2 
are the result of cell-intrinsic defects or defects in the bone marrow microenvironment. 
 
1.14 There are numerous unanswered questions regarding B cell development and 
aging. 
B cell development is reduced in aged mice and is characterized by a severe 
reduction in numbers of pre-B cells (90, 95, 96, 98, 101, 102).   In addition, expression of 
both rag1 and rag2 are reduced in the bone marrow of aged mice.  However, before this 
work, it was not known if rag expression was reduced in pro-B cells.  And it was not 
known if a reduction in rag expression results from a reduction in expression in the 
percent of pro-B cells that express rag or due to reduced per cell expression (or both).  In 
addition, until this work, it was not known if the drop in rag expression is consistent with 
a decrease in V(D)J recombinase activity.  It was possible that rag expression levels 
decline but are still sufficient for effective V(D)J recombination.  Furthermore, it was 
unknown as to whether reduced rag expression contributes to loss of pre-B cells in aged 
mice.  In addition, it was not known if loss of pre-B cells in aged mice was the result of 
defects in the bone marrow microenvironment or cell intrinsic defects.  These questions 
are addressed in Chapter 2. 
 
Another area that had not been addressed is the impact that genetics has on age-
associated defects in B cell development.  It is possible that the impact of age-associated 
defects in B cell development and immunity are regulated by specific genes, and that 
certain alleles provide increased or reduced susceptibility to age-related defects. The 
identification of these genes could eventually lead to new therapeutics to restore 
generation of mature B cells in the aged. 
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Furthermore, the relationships between B cell development and other lymphocyte 
populations in aging have not been explored.  In aged mice, there are reduced numbers of 
pro- and pre-B cells, and an increase in the number of re-circulated mature B cells in the 
bone marrow.  In addition, reduction in size and output by the thymus occurs with age 
and there is an increase in anergic and memory peripheral T cells (103).   It is possible 
that these changes in peripheral T cell subsets contribute to altered B cell development.  
Or it may be that age-associated changes in B and T cells are the result of a common 
underlying mechanism.  It is also possible that B and T cell changes occur independent of 
each other and result from independent mechanisms.  These questions are addressed in 
Chapter 3. 
 
1.15 Approach and summary of results. 
Expression of rag2 is lower in pro-B cells of aged mice. 
In this thesis I have compared expression of rag2 and V(D)J recombinase activity at 
the single-cell level in pro-B cells from young and aged mice (Chapter 2),.  To 
characterize expression of rag2, I used two different mouse strains that contain GFP as 
reporters of rag2 expression (discussed below). As rag1 and rag2 are co-ordinately 
regulated measurement of rag2 expression is expected to serve as an indicator of 
expression of both genes. 
 
The GFP transgenic rag2 reporter (NG strain) was created in the lab of Dr. Michel 
Nussenzweig  (80).  In this system, GFP serves as a reporter of rag2 gene expression.  
The transgene contains 200 kb of the rag genomic locus, with GFP inserted in place of 
the major rag2 exon. The mice retain normal RAG2 function because the endogenous 
rag2 locus remains intact.  In addition, the transgene does not affect the development or 
health of mice.  The GFP in this transgene is an accurate and sensitive reporter of rag2 
transcription levels and enzymatic activity (80). 
 
 The second model used in this work is a RAG2-GFP fusion protein knock-in (KI) 
mouse made in the lab of Dr. Fred Alt (81).  These KI mice are accurate reporters of 
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RAG2 levels in single cells, and have two important advantages compared to NG mice: 
1) the GFP reporter is located within the endogenous rag2 locus, and 2) GFP is expressed 
as a fusion protein with RAG2 and thus serves as a direct reporter of cellular RAG2 
protein levels.  In these mice, the RAG2-GFP fusion protein maintains normal RAG2 
enzymatic activity and B cell development is not altered. 
 
Through FACS analysis of GFP fluorescence, the expression of rag2 can be assessed 
at the single-cell level in conjunction with surface markers used to define distinct stages 
of B cell development.  This provides two advantages over previously used methods: 1) 
measurement of the level of rag2 expression in live, single cells rather than lysates of 
bulk cell populations, and 2) assessment of rag2 expression within pro-B cells.  Using 
these systems I was able to directly analyze rag2 expression at the single cell level and 
determine that rag2 expression is reduced in pro-B cells of aged mice.  Reduced rag2 
expression in pro-B cells of aged mice is due to expression in fewer cells, as the pro-B 
cell that express rag2 have “per cell” levels that are comparable between young and age 
mice.   
 
1.16 Reduced expression of rag2 is consistent with reduced recombinase activity in 
pro-B cells and reduced numbers of pre-B cells. 
In this work, an assessment of V(D)J recombinase activity at the single cell level in 
pro-B cells was also conducted to determine if the loss of rag2 expression in aged mice 
was consistent with a loss of V(D)J recombinase activity.  This was done using H2-
SVEX V(D)J recombination substrate transgenic mice created in our lab.  In this 
transgenic mouse VEX, a spectrally-distinct form of GFP, (104) serves as a reporter of 
V(D)J recombinase activity. Expression of the H2-SVEX transgene is driven by the 
MHC class I promoter (active throughout all hematopoietic cells), and is therefore 
independent of B-cell-specific transcription regulation (82).  Cellular GFP fluorescence is 
acquired following recombination of the transgene and is dependent upon sufficient 
expression and activity of all factors required for V(D)J recombination.  Using H2-SVEX 
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x NG double transgenic mice, I measured rag2 expression and V(D)J recombinase 
activity to determine if the aged-related decrease in rag2 expression results in decreased 
V(D)J recombinase activity and generation of pre-B cells.  I found that V(D)J 
recombinase activity is reduced in pro-B cells of aged mice, and correlated with the 
reduction in rag2 expression.  Furthermore, the losses of rag2 expression and V(D)J 
recombinase activity in aged mice were associated with reduced numbers of pre-B cells.  
Aged mice with the most severe loss of rag2 expression and V(D)J recombinase activity 
also had the most severe loss of pre-B cells.  In other mice, loss of rag2 expression was 
minimal compared to young mice, and recombinase activity and numbers of pre-B cells 
were only marginally decreased.  These results are consistent with the hypothesis that the 
decline in pre-B cell numbers in aged mice is due to reduced rag2 expression in pro-B 
cells. 
 
1.17 Age-associated defects in the bone marrow microenvironment are sufficient to 
produce reduced rag2 expression and V(D)J recombinase activity in pro-B cells, and 
reduced numbers of pre-B cells. 
I conducted reciprocal adoptive transfer experiments to determine if reduced rag2 
expression and V(D)J recombinase activity in pro-B cells, and reduced numbers of pre-B 
cells are due to defects in the bone marrow microenvironment or the results of cell-
intrinsic defects.  Adoptive transfer of whole bone marrow from young mice into mice of 
various ages was used to assess defects due to the aged microenvironment.  Donor mice 
were NG x H2-SVEX double transgenic mice.  This provided the ability to measure both 
rag2 expression and V(D)J recombinase activity in pro-B cells and compare numbers of 
pre-B cells.  Using this system, I determined that age-associated changes in the 
hematopoietic microenvironment are sufficient to produce reduced rag2 expression, 
V(D)J recombinase activity and pre-B cells (Chapter 2).   
 
To specifically determine if the loss of pre-B cells is influenced by cell-intrinsic 
defects in aged mice, I conducted adoptive transfers from aged and young mice into 
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young recipient mice.  Donor mice were aged NG transgenic mice that had notable 
defects in rag2 expression in pro-B cells and reduced numbers of pre-B cells.  Recipient 
mice were young, wild-type mice.  In Chapter 2, I show that bone marrow from aged 
mice is not intrinsically defective in regards to ability to express rag2 in the pro-B cell 
stage and generate numbers of pre-B cells. 
 
1.18 Frequencies of pre-B cell and re-circulating B cell in the bone marrow of aged 
mice are influenced by specific genetic polymorphisms. 
In order to determine if genetic differences between mouse strains contribute to the 
age-related loss of pre-B cells, I conducted a Quantitative Trait Locus (QTL) analysis in 
collaboration with Dr. Richard Miller (University of Michigan).  This analysis compared 
87 simple-sequence length polymorphisms (SSLPs), and B cell developmental subsets 
and peripheral T cell subsets in a genetically heterogeneous cohort of aged mice.  This 
cohort (termed UM-HET3) was produced by mating BALB/c x C57BL/6 F1 females and 
C3H/HeJ x DBA/2J F1 males.  These four strains were selected because they are spread 
wide apart in their ancestral lineage (105) and thus should maximize allelic variation 
within the cohort.  In addition, information on genetic variations between these strains, 
including SSLPs, is available. This method has been successful in identifying 
polymorphisms related to longevity (8) and age-related T cell phenotypes (7).  We 
expected this cohort to display diversity with respect to age-related alterations in B cell 
developmental subsets and thus enable us to determine if genetic polymorphisms between 
these strains are associated with the age-related changes in B cell development. In 
addition, frequencies of peripheral T cell subsets and T cell proliferation were compared 
with frequencies of B cell subsets to determine if correlations exist.  These could suggest 
cause and effect relationships or common mechanisms. 
 
In Chapter 3, I present evidence that the frequencies of pre-B cells and re-circulated 
B cells in aged mice are influenced by specific genetic loci.  A polymorphism located on 
chromosome 19 is correlated with frequencies of pre-B cells and a polymorphism on 
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chromosome 15 is correlated with frequencies of re-circulated B cells in the bone 
marrow.  
 
1.19 Analysis of relationships between B cell subsets in the bone marrow and 
peripheral T cell subsets.   
I also wanted to determine if frequencies of B cell precursors in the bone marrow 
were associated with T cell subsets in the periphery.  The aged cohort of UM-HET3 mice 
was used in this analysis.  In Chapter 3, I show that the frequency of pre-B cells in aged 
mice is not correlated with frequencies of peripheral memory or anergic T cell subsets. 
However, the frequency of pre-B cells is inversely correlated with the frequency of 
B220intIgM+ cells in the bone marrow, and frequency of re-circulated B cells is associated 
with the frequency of peripheral anergic T cells (described in Chapter 3). 
 
These observations contribute to our understanding of the age-related impact on B 
cell development in mice and suggest that therapeutics to restore B cell production in 
aged humans may come from better understanding of the changes in the bone marrow 
microenvironment. 
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CHAPTER II 
 
Expression of rag2 and V(D)J recombinase activity are reduced in pro-B cells of 
aged mice and are correlated with loss of pre-B cells. 
 
INTRODUCTION 
In both aged humans and aged mice, the adaptive immune response is severely 
compromised and characterized by decreased ability to respond to new pathogens (2, 106, 
107) and less protective immunity following vaccination (108, 109). These changes are 
due, in part, to decreased production of B lymphocytes and loss of diversity of the 
immunoglobulin (Ig) repertoire (3, 9, 97-99, 110-113).  However, the molecular 
mechanisms that underlie age-associated diminished B cell production remain unclear. 
 
V(D)J recombination is essential to the production of lymphocytes as it assembles Ig 
and T-cell receptor genes during B and T cell development.  Recombinase Activating 
Genes, rag1 and rag2, are lymphocyte-lineage specific proteins that are coordinately 
expressed during B and T cell development (22-24).  rag1 and rag2 are required to 
produce site-specific DNA double-strand breaks that initiate V(D)J recombination (22, 
23). rag1 and rag2 gene expression is up-regulated in pro-B cells when the Ig heavy 
(IgH) chain is assembled, and in pre-B cells when the Ig light (IgL) chain is assembled 
(22, 23).  The Ig heavy chain is an essential component of the pre-B cell receptor (pre-
BCR), which transmits signals that enable progression from the pro- to pre-B cell stage of 
development (114, 115).  In the absence of rag1 or rag2, an intact IgH chain is not 
produced resulting in a complete arrest of B cell development at the pro-B cell stage (43, 
44). 
 
B cells are generated continuously during life (9).  This process is impaired in aged mice; 
one specific change is fewer pre-B cells are found in bone marrow (3, 90, 91, 101).  
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There are several possible explanations for this:  1) reduced production of pre-B cells due 
to impaired development of pro-B cells, 2) decreased survival of pre-B cells or 3) an 
acceleration of the transit time between the pre-B and immature B stages of development.  
Reduced production is likely to be the major contributing factor based on several 
observations.  Development within the pro-B cell population is impaired in aged mice, as 
indicated by reduced numbers of cells in the more mature pro-B cell stages and reduced 
expression of 5 in pro-B cells (91, 95, 96).  Also, recent kinetic analyses indicate young 
adult mice generate 9 to 13 million pre-B cells daily, whereas aged individuals produce 
only 2 to 5 million pre-B cells per day (personal communication, Dr. Michael Cancro 
[addressed in Chapter 4 Discussion]).  Nonetheless, the renewal rates of pre-B cells are 
very similar in young and aged mice (32 to 42% per day), indicating that the residency 
time within the pre-B cell pool is unchanged in aged individuals (personal 
communication, Dr. Michael Cancro [addressed in Chapter 4 Discussion]).  An age-
associated reduction of rag expression in pro-B cells, and a resulting reduction in V(D)J 
recombinase activity may contribute to decreased size of the pre-B cell compartment in 
aged mice. 
 
rag1 and rag2 mRNA levels decline dramatically when measured in the total bone 
marrow of aged mice (3, 97, 98). However, it is unknown if this reduction is the result of 
diminished numbers of cells within the developmental stages where rag1 and rag2 are 
expressed, or reduced rag expression within those subsets.  It is possible that the age-
associated reduction in pre-B cells alone could account for the reduction in rag 
expression when measured in total bone marrow.  This is supported by the observation 
that the reduction in pre-B cells is extensive in aged mice; whereas pre-B cells outnumber 
pro-B cells 3:1 in young mice, they are often equal to, or less than, the number of pro-B 
cells in aged mice (3, 90, 91, 101). Alternatively, reduced rag1 and rag2 expression in 
aged mice may be due to a reduction in the frequency of pro- and pre-B cells that express 
rag1 and rag2.  Rag1 and rag2 expression levels are expected to determine and limit 
levels of V(D)J recombinase activity (82, 116-118); thus a reduction in rag expression 
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within these subsets could impair recombination.  However, an assessment of rag 
expression levels or V(D)J recombinase activity in developing B cell precursors in aged 
mice has not been conducted. 
 
It is unknown if the age-related reduction in B cell development is the result of 
changes in the bone marrow microenvironment or due to cell-intrinsic defects.  Evidence 
for cell-intrinsic defects includes the observation that in vitro cultures supplemented with 
IL-7 drive less proliferation of sIg- precursors and pro-B cells from aged mice versus 
young mice (90, 93, 100).  Evidence for changes in the microenvironment include the 
finding that expression of both rag1 and rag2 in total bone marrow and numbers of pre-B 
cells are reduced in athymic mice (97, 98).  In addition, stromal cell cultures established 
from aged mice support less in vitro proliferation of pro-B cells or pre-B cell lines than 
cultures established from young mice (93, 94, 101).  Here, we ask whether rag2 
expression is decreased within pro-B cells of aged mice, and whether this decrease is 
concurrent with a reduction in V(D)J recombinase activity and thus may explain the 
decreased numbers of pre-B cells.  To gain insight into rag2 expression and its effect on 
regulation of V(D)J recombination during aging, we conducted flow cytometric analyses 
of bone marrow from the following young and aged mice: 1) transgenic mice that express 
a GFP reporter of rag2 transcription (24), 2) knock-in mice that express GFP as a reporter 
of rag2 transcription and RAG2 protein (81), and 3) double transgenic mice in which the 
rag2 expression reporter system is paired with a transgenic reporter of V(D)J 
recombinase activity (82).  This approach enabled us to determine that the lower pre-B 
cell number in aged mice is correlated with changes that occur in the pro-B cell stage of 
development and include both reduced expression of rag2 and reduced V(D)J 
recombinase activity. 
 
We also addressed if age-related defects in B cell development are the result of an 
altered bone marrow microenvironment or changes that are intrinsic to developing B 
cells.  We distinguish the impact of the aged microenvironment and cell intrinsic defects 
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by using an adoptive transfer model.  We found that alterations in the hematopoietic 
microenvironment of aged mice are sufficient to produce the reduction in rag2 expression 
and V(D)J recombinase activity in pro-B cells and the reduced numbers of pre-B cells. 
 
These results lead to the conclusion that defects in B cell development in aged mice 
occur as early as the pro-B cell stage of development and suggest that diminished 
expression of rag2 and reduced V(D)J recombinase activity are associated with reduced 
numbers of pre-B cells.  In addition, our observations indicate that defects in the aged 
bone marrow microenvironment are sufficient to result in reduced B cell development.  
This suggests that extrinsic factors in the bone marrow that decline with aging could be 
identified and lead to development of therapeutics for age-related defects in human B cell 
development.  
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MATERIALS AND METHODS  
Mice 
C57BL6J, CBA/J, FVBN/J and B6.SJL-Ptprca Pep3b/BoyJ (CD45.1) were obtained 
from Jackson Laboratories (Bar Harbor, ME). NG transgenic mice on the FVBN 
background were obtained from Michel Nussenzweig (Rockefeller University, NY, NY) 
(24, 80).  NG transgenic mice were mated to CBA/J wild type mice to create F1. NG 
mice were also crossed to C57BL6/J mice for six to nine generations, and then crossed to 
H2-SVEX mice and B6.SJL-Ptprca Pep3b/BoyJ (CD45.1) mice.  RAG2:GFP Knock-in 
mice on a mixed 129 x C57BL/6 background were provided by Fred Alt (Harvard 
Medical School, Boston, MA)(81).  H2-SVEX mice (SB110 line) on the C57BL/6 
background were constructed as described in Borghesi et al. (82).  Aged C57BL/6 mice 
used as adoptive transfer recipients were obtained from either The National Institute of 
Aging Repository at Harlan Sprague Dawley (rederivation in 1998, from Jackson 
Laboratory stock) or from Dr. Raymond Welsh (Dept. of Pathology, UMMS; obtained 
from Jackson Laboratories (Bar Harbor, ME) at 2-4 months of age and housed in Specific 
Pathogen Free conditions).  Unless indicated otherwise, all mice were maintained by the 
Department of Animal Medicine, UMMS. 
 
Adoptive transfers   
For adoptive transfers of bone marrow from young mice into young and aged 
recipient mice, bone marrow was harvested from leg bones of 3 - 12 week old NGxH2-
SVEX double transgenic mice on the C57BL/6 CD45.1 background.  Bone marrow from 
multiple donors was pooled, washed in Hanks’ Balanced Salt Solution (Life 
Technologies, Rockville Maryland, Cat. 14025), and suspended to 10 million cells per 
ml.  Young and aged recipient mice received lethal irradiation (850-1000 rads) 16-20 
hours prior to adoptive transfer. Recipient mice received 3.5 or 6 million cells via tail 
vein injection. Neomycin sulfate (Sigma N-6386) and polymyxin B sulfate (Sigma P-
4932) were administered through drinking water starting 4 days prior to irradiation and 
ending 14 days post adoptive transfer.  Water bottles were changed every two days. Five 
to six weeks after adoptive transfer, bone marrow was harvested from recipient mice for 
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analysis. At this time point, pro- and pre-B cells detected in the recipient mice have 
presumably differentiated from hematopoietic stem cells or very early progenitors present 
in the transferred marrow (17, 119).  Gross inspection of young and aged mice was 
performed prior to and after euthanasia.  Mice displaying signs of tumors or other 
abnormalities were eliminated from analysis.  In addition, mice were excluded from 
analysis if less than 30% of pro-B cells were of donor origin. This criterion resulted in 
exclusion of seven out of 37 mice as engraftment was efficient in most mice (11 out of 17 
aged mice and all young mice had over 85% engraftment).  Although generally efficient, 
engraftment varied between mice, and therefore absolute cell numbers were not used in 
analysis.  Surface expression of CD45.1 served as a marker of donor derived cells and 
was detected using the A20 monoclonal antibody. 
 
For adoptive transfers of bone marrow from young and aged mice into young 
recipient mice, bone marrow was harvested from leg bones of young and aged F1 (FVBN 
x CBA) mice.  Cells from individual donors were not pooled.  Bone marrow was washed 
in Hanks’ Balanced Salt Solution (Life Technologies, Rockville Maryland, Cat. 14025) 
and suspended to 10 million cells per ml.  Young recipient mice received lethal 
irradiation (950 rads) 20 hours prior to adoptive transfer.  Recipient mice received 5 
million cells from either a young or aged donor via tail vein injection.  Neomycin sulfate 
and polymyxin B sulfate were used as indicated above.   Five weeks after adoptive 
transfer, bone marrow was harvested from young recipient mice for analysis. Gross 
inspection of young and aged mice was performed prior to and after euthanasia.  Mice 
displaying signs of tumors or other abnormalities were eliminated from analysis. 
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Flow cytometric analysis 
Cells were flushed from the leg bones with ice-cold staining medium [RPMI 1640 
deficient for biotin, flavin, and phenol red (Irvine Scientific, cat# 9826, Santa Ana, CA), 
with 10 mM HEPES pH 7.2, 0.02% sodium azide, 1 mM EDTA and 3% newborn calf 
serum] using a 22-g needle.  Freshly isolated cells were washed and suspended at 3 x 
107/ml in staining medium. Cells were treated for 10 minutes on ice with purified 
antibody (2.4G2) to block Fc receptors. Cells were incubated with primary antibodies for 
20 minutes followed by three washes, then incubated with streptavidin-Cy5-PE for 15 
minutes, followed by three washes.   Cells were re-suspended in staining medium with 
propidium iodide (1 g/ml) to exclude dead cells. 
 
Primary antibodies specific for the following were used: CD24(30F1)-Alexa594, 
CD24-Cascade Blue, CD43(S7)-PE, 493-Biotin, CD45.1 (A20)-Cascade Blue, AA4.1-
Alexa 594, AA4.1-Biotin, B220(RA3-6B2)-APC, B220-Biotin, DX5-Biotin, IgM(331)-
Alexa 594, IgM-Biotin, IgM-Cascade Blue and Ly6C(AL21)-Biotin.  StrepAvidin-
Cy5PE was used to reveal biotinylated reagents.  Antibodies were purchased from 
PharMingen (San Diego, CA), eBioscience (San Diego, CA) or CALTAG (Burlingame, 
CA).  CD24, CD45.1, AA4.1 and IgM antibodies were purified and conjugated to 
Cascade Blue and Alexa 594 (Molecular Probes, Inc., Eugene, OR) in our laboratory 
using standard methods.  rag2 gene expression (NG transgenics and RAG2-GFP knock-
in) was evaluated by detection of GFP using 488nm excitation (argon laser) and a band 
pass filter of 510 + 20. V(D)J recombinase activity was evaluated by detection of VEX 
(H2-SVEX transgenic) using 407nm excitation (krypton laser) and a band pass filter of 
510 + 20.  Flow cytometry was performed on a 3-laser (argon, krypton and dye laser 
tuned to 600 nm), 10 parameter FACSVantage from BD Biosciences Immunocytometry 
Systems.  Post-hoc compensation and data analyses were performed using FlowJo 
software (Tree Star, San Carlos, CA).  Stages of B cell development were identified by 
previously used methods (18). 
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Statistical analysis 
Differences between groups were evaluated by either the Welch-Aspin t or the Student’s t 
Test (depending on whether or not there was significant heterogeneity of variances as 
determined by Levene’s Test for Equality of Variances).  Analysis of Covariance was 
used to evaluate differences between groups while controlling for the number of pro-B 
cells.  Differences between groups were defined as statistically significant when their 
probability of occurrence by chance alone was lower than 0.05.  For tests of 
heterogeneity of variances a threshold of 0.1 was used so as to be conservative in order to 
protect against violations of the assumption of heterogeneity.  All correlations 
represented are Pearson Correlations.  All analyses were performed using SPSS version 
10.0 for Macintosh (SPSS, Chicago IL).  Statistical analyses were performed under the 
supervision of Mr. Steven Baker, Dept. of IS, UMMS. 
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RESULTS 
Age-associated reduction in pre-B cells is correlated with a reduction in the percent 
of pro-B cells that express rag2. 
Reduced expression of rag in developing pro-B cells could explain the reduced 
numbers of pre-B cells in aged mice.  However, it remains unknown if rag expression is 
reduced specifically within pro-B cells of aged mice.  In addition, the reduction in 
numbers of pre-B cells is highly variable between aged mice even of the same inbred 
strain (90, 95, 101), and it is not known if rag expression is reduced in all aged mice, or 
only in those in which the number of pre-B cells is reduced. 
 
To address these questions we compared numbers of pro- and pre-B cells in young 
and aged NG transgenic mice.  In these mice GFP serves as a reporter of rag2 gene 
expression (24, 80).  This allowed us to compare rag2 expression in pro-B cells with the 
absolute numbers of pre-B cells in young versus aged mice.   The NG transgene contains 
180 kb of the rag genomic locus in which GFP is inserted in place of the major rag2 
exon.  The endogenous rag locus is intact and retains all of the normal regulatory 
elements necessary for developmentally-regulated rag expression.  These mice retain 
normal generation of lymphocytes.  Using flow cytometric analysis of GFP, the 
expression of rag2 can be accurately assessed at the single-cell level in conjunction with 
cell surface markers that define distinct stages of B cell development (24, 80).  This 
method of analysis provides two advantages over previous determinations of rag 
expression in aged mice:  1) measurement of the level of rag2 expression in single, live 
cells rather than in lysates from total bone marrow, and 2) a measure of rag2 expression 
within cells at specific stages of B cell development.   
 
In order to examine reduced numbers of pre-B cells and rag2 expression in pro-B 
cells we analyzed bone marrow from young (2-3 month) and aged (26-27 months) NG 
transgenic (FVBN x CBA) F1 mice.  Representative analysis of pro-B cells 
(B220+CD43+AA4.1+) and pre-B cells (B220+CD43-AA4.1+CD24++) is shown in Figure 
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2A.  Inclusion of AA4.1 in this analysis ensures that mature re-circulating B cells and 
non-B lineage cells are excluded and allows the accurate identification of AA4.1+CD24++ 
pre-B cells (17, 120-122) (and data not shown).  We found that the number of pre-B cells 
was significantly lower in aged mice (n=5) as compared to young mice (n=6) (mean = 1.3 
+0.79 versus 4.1 + 1.0 million cells; p= 0.001; Figure 2B and Table 1A).  In addition, the 
number of pro-B cells was marginally, but statistically significant, lower in aged mice as 
compared to young mice (mean = 0.70 + 0.12 versus 1.0 + 0.29 million cells; p= 0.035).  
Using an analysis of covariance we determined that the age-related reduction in number 
of pre-B cells is still significant when controlling for differences in the number of pro-B 
cells between young and aged mice.  This suggests that the loss of pre-B cells in aged 
mice is not solely the result of a smaller precursor pool of pro-B cells. 
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FIGURE 2.  Reduced rag2 expression in pro-B cells is consistent with lower 
numbers of pre-B cells in aged mice. Bone marrow from young (2-3.5 months) and 
aged (26-27 months) NG mice, and wild type F1 (FVBN x CBA) controls was stained 
with antibodies to B220, CD43, AA4.1 and CD24 and analyzed by flow cytometry. (A) 
Flow cytometric analysis from a representative young wild type mouse.  Labels above 
panels indicate the phenotype of the cells displayed in each graph, and the number 
reflects the percent of displayed cells within the gate.  The pre:pro ratio is calculated by 
dividing the number of pre-B cells (B220intCD43-AA4.1+CD24++) by the number of pro-
B cells (B220+CD43+AA4.1+).  (B) Numbers of pro- and pre-B cells in bone marrow of 
young and aged mice.  Open bars represent pro-B cells, closed bars represent pre-B cells.  
(C) Flow cytometric analysis of GFP (a reporter of rag2 expression in NG mice) in pro-B 
cells from young and aged NG mice.  Bone marrow pro-B cells from wild type, young 
NG, aged NG with a moderate loss of GFP expression and an aged NG with a severe loss 
of GFP expression are displayed.  The numbers within the gates depict the percent of pro-
B cells that express GFP.  (D) The percent of pro-B cells that are GFP+ are shown for the 
same mice depicted in B.  (E) The percent of pro-B cells that are GFP+ and the pre:pro 
ratio are displayed for each NG mouse shown in B and D.  Closed diamonds represent 
young mice, open diamonds represent aged mice. 
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TABLE 1.  Statistical Analysis of Data Obtained from Young and Aged NG Mice. 
Analysis of the young and aged NG mice shown in Figure 2.  (A) The mean, standard 
deviation and significance of differences in means between young and aged mice groups 
are shown.  (B) The correlations between traits are shown. 
 
 
A.  Significance of Differences Between Young and Aged Groups 
   young      aged p-value 
Number of pro-B cells (millions) 1.0 + 0.29 0.70 + 0.12  0.035 
Number of pre-B cells (millions) 4.1 + 1.0 1.3   + 0.79  0.001 
Pre:pro ratio 4.0 + 0.67 1.7   + 0.94  0.001 
Percent of pro-B cells that are CD24high 61  + 4.1 45    + 10  0.005 
Percent of pro-B cells that are GFP+ 74  + 2.7 45    + 19  0.026 
 
 
B.  Correlation Between Characteristics 
  n    r p-value 
Percent of pro-B cells that are that GFP+ and number of pre-B cells 11 0.80   0.003 
Percent of pro-B cells that are GFP+ and pre:pro ratio 11 0.88 <0.001 
 
(n = number of mice, r = correlation coefficient, p = significance) 
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In addition to the number of pre-B cells, the ratio of pre:pro B cells can provide an  
indicator of pre-B cell dynamics.   Reduced pre-B cell numbers could be due to reduced 
generation, and or maintenance of pre-B cells rather than solely the result of reduced 
numbers of precursors in the pro-B cell stage.  The pre:pro ratio was significantly lower 
in aged versus young mice (mean = 1.7 +0.94 versus 4.0 +0.67; p= 0.001; Figure 2A), 
suggesting that the reduction in the numbers of pro-B cells in aged mice does not 
completely account for the reduction in the numbers of pre-B cells.   Expression of CD24 
increases as cell mature within the pro-B cell stage (123).  Using CD24 as an indicator of 
maturation within the pro-B cell stage (18, 123), we observed that the percent of pro-B 
cells that are CD24high is significantly lower in aged mice as compared to young mice 
(mean = 45 +10 versus 61 + 4.1 %; p= 0.005; Table 1A).  Together, these observations 
support the concept that B cell development is altered in aged mice as early as the pro-B 
cell stage and that reduced developmental progression of pro-B cells may contribute to 
the lower numbers of pre-B cells observed in aged mice. 
 
Rag2 expression is essential to V(D)J recombination and generation of an intact IgH 
chain which is required  for pre-B cell production.  Expression of rag2 is reduced in total 
bone marrow of aged mice, but it is unknown if expression is lower within pro-B cells. 
Therefore, we compared rag2 expression in the bone marrow of young and aged mice to 
determine if rag2 expression is lower within pro-B cells, and if this reduction is 
correlated with the reduction in the number of pre-B cells.   Flow cytometric analysis of 
the young and aged NG transgenic mice was used to determine the percent of pro-B cells 
that express GFP as a reporter of rag2 expression (Figure 2C and Figure 2D). The percent 
of pro-B cells that are GFP+ is significantly lower in aged mice as compared to young 
mice (mean = 45 +19 versus 74 + 2.7 percent; p= 0.026; Table 1A).  This indicates that 
the percent of pro-B cell that express rag2 is reduced in aged mice.  In the pro-B cells 
that do express GFP, the per cell levels, as measured by the mean fluorescent intensity of 
GFP, was similar between young mice and aged mice.  This suggests that the levels of 
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rag2 per pro-B cell are similar in young and aged mice, even though fewer pro-B cells 
express rag2 in aged mice.  
 
The loss of rag2 expression in pro-B cells is correlated with reduced numbers of pre-
B cells.  We found that the percent of pro-B cells that are GFP+ is correlated with both 
the number of pre-B cells (n=11, r=0.80, p=0.003) and the pre:pro ratio (r= 0.88, 
p<0.001) (Table 1B and Figure 2E).  This relationship is also evident in Figure 2B, as the 
aged mouse with the lowest percent of GFP+ pro-B cells is the same mouse that has the 
lowest number of pre-B cells and pre:pro ratio.   
 
Together, these results indicate that the percent of pro-B cells that express rag2 is 
reduced in aged mice and is correlated with the reduction in pre-B cell numbers.  This 
supports the hypothesis that reduced numbers of pre-B cells in aged mice are due to 
defects in B cell development that occur during the pro-B cell phase of development and 
that affect expression of rag2. 
 
Of the five aged mice, there is one mouse in which the number of pre-B cells, the 
pre:pro ratio and the percent of pro-B cells that are GFP+ are considerably lower than the 
other 4 mice.   This raises the concern that one aged mouse could account for the majority 
of the differences observed between young and aged mice.  A statistical analysis of the 
young and aged mice was conducted in which this mouse was excluded.  Among the 
remaining four aged mice, the mean number of pre-B cells was 1.6+0.57 million and the 
difference between young and aged mice was still significant (p= 0.001).  In addition, the 
mean pre:pro ratio was 2.1+0.65 and difference between young and aged mice was still 
significant (p=0.002).   Furthermore, the mean percent of pro-B cells that are GFP+ in the 
four aged mice was 53+6.1 and the difference between young and age mice was still 
significant (p= 0.004).  Thus exclusion of the aged mouse with the most extreme 
phenotype does not alter the observations that the number of pre-B cells, the pre:pro ratio 
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and the percent of pro-B cells that are GFP+ are all significantly reduced in aged, as 
compared to young, mice. 
 
Reduced numbers of pre-B cells in aged mice is correlated with reduced RAG2 
protein levels in pro-B cells. 
We next analyzed B cell development in RAG2-GFP knock-in (KI) mice (81).  
These KI mice are accurate reporters of RAG2 levels in single cells, and have two 
important advantages compared to NG mice: 1) the GFP reporter is located within the 
endogenous rag2 locus, and 2) GFP is expressed as a fusion protein with RAG2 and thus 
serves as a direct reporter of cellular RAG2 protein levels.  In these mice the RAG2-GFP 
fusion protein maintains normal RAG enzymatic activity and B cell development is not 
altered.  GFP levels per cell and the percent of pro-B cells that are GFP+ are lower in 
these mice compared to the NG transgenic mice.  This difference could be due to the 
single insertion of GFP in the KI compared to a multi-copy NG transgene as well as 
differences in protein half-life for the RAG2-GFP fusion in the KI compared to GFP in 
the transgenic.  We analyzed RAG2-GFP expression in pro-B cells harvested from young 
(4-7 months) and aged (23-28 months) RAG2-GFP KI mice.  Representative flow 
cytometric analysis of pro-B cells (IgM-B220+CD43+) and pre-B cells (IgM-B220+CD43-) 
is shown in Figure 3A.  Cells that could contaminate pro-B and pre-B cell populations 
were excluded based on expression of either Ly6C (myeloid, activated T and B cells, 
plasma cells, plasmacytoid dendritic cells) or DX5 (NK, NKT) (124, 125).  This is 
functionally equivalent to using AA4.1 to positively identify cells of pro-B and pre-B 
cells (data not shown). 
 
As with the NG mice, the percent of pro-B cells that express rag2 was significantly 
lower in the aged KI mice as compared to the young KI mice (mean = 14 + 12 versus 33+ 
3.6 %; p= 0.001; Figure 3D and Table 2A). Both models demonstrate that rag2 
expression in pro-B cells is lower in aged mice. Also, because the KI reporter is a RAG2-
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GFP fusion protein, the data suggest that protein levels of RAG2 are lower in the pro-B 
cells of aged mice. 
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FIGURE 3.  Reduced RAG2 protein levels in pro-B cells are correlated with lower pre-B 
cell numbers in aged mice.
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FIGURE 3.  Reduced RAG2 protein levels in pro-B cells are consistent with lower 
numbers of pre-B cells in aged RAG2-GFP knock-in mice.  Bone marrow from young 
(4-7 months) and aged (23-28 months) RAG2-GFP knock-in mice was stained with 
antibodies to Ly6C, DX5, IgM, B220 and CD43 and analyzed by flow cytometry. (A) 
Representative flow cytometric analysis of a young, wild type mouse.  Label above 
panels indicate the phenotype of cells displayed in each graph, and the number near each 
gate reflects the percent of displayed cells within the gate.  Pro-B cells (Ly6C-DX5-IgM-
B220+CD43+) and pre-B cells (Ly6C-DX5-IgM-B220+CD43-) are shown in the right 
panel.  (B) Numbers of pro- and pre-B cells in bone marrow of young and aged mice.  
Open bars represent pro-B cells, closed bars represent pre-B cells. The pre:pro ratio was 
calculated by dividing the number of pre-B cells by the number of pro-B cells.  (C) 
Analysis of GFP in pro-B cells of RAG2-GFP knock-in mice.  Bone marrow from young 
wild type, young RAG2-GFP knock-in, aged RAG2-GFP knock-in with a moderate loss 
of GFP expression, and an aged RAG2-GFP knock-in with severe loss of GFP expression 
are displayed.  The numbers within the gates depict the percent of pro-B cells that express 
GFP.  (D) The percent of pro-B cells that are GFP+ are displayed for the same mice 
shown in B.  (E) The percent of pro-B cells that are GFP+ and the ratio of pre-B to pro-B 
cells are displayed for each knock-in mouse shown in B and D.  Closed squares represent 
young mice, open squares represent aged mice. 
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TABLE 2.  Statistical Analysis of Data Obtained from Young and Aged RAG2-GFP 
Knock-in Mice. 
Analysis of the young and aged RAG2-GFP knock-in mice shown in Figure 3.  (A) The 
mean, standard deviation and significance of differences in means between young and 
aged mice groups are shown.  (B) The correlations between traits are shown. 
 
 
A.  Significance of Differences Between Young and Aged Groups 
     young      aged p-value 
Number of pro-B cells (millions) 0.28 + 0.07 0.21 +  0.12  NS 
Number of pre-B cells (millions) 1.0   + 0.64 0.33 +  0.35  0.019 
Pre:pro ratio 3.4   + 1.2 1.3   +  0.75  0.001 
Percent of pro-B cells that are GFP+ 33    + 3.6 14    + 12  0.001 
 
 
 
B.  Correlation Between Characteristics 
  n      r p-value 
Percent of pro-B cells that are GFP+and number of pre-B cells 16 0.575   0.020 
Percent of pro-B cells that are GFP+and pre:pro ratio 16 0.709   0.002 
 
(n = number of mice, r = correlation coefficient, p = significance, NS = not significant) 
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The number of pre-B cells was significantly lower in aged KI mice as compared to 
young KI mice (mean = 0.33 +0.35 versus 1.0 + 0.64 million cells; p= 0.019;Table 2A).  
We found that the number of pro-B cells was not significantly different between young 
and aged mice (mean =0.28 +0.070 and 0.21 + 0.12 million cells).  In addition, the 
pre:pro ratio was lower in the aged mice as compared to young mice (mean = 1.3 
+0.75versus  3.4 +1.2; p= 0.001; Table 2A).  Similar to our data with the NG mice, these 
results suggest that the reduction in the numbers of pre-B cells in aged mice is not solely 
due to a reduction in the size of the precursor population of pro-B cells, and may also 
reflect reduced development of pro-B cells and generation of pre-B cells.   
 
Furthermore, we observed that the percent of pro-B cells that express GFP was 
correlated with both the number of pre-B cells (n=16, r=0.575, p=0.020) and the pre:pro 
ratio (n= 16, r=0.709, p=0.002) (Table 2B).  The relationship is also evident in the data 
depicted in Figure 3E: the aged RAG2-GFP KI mice that displayed the lowest numbers of 
pre-B cells and pre:pro ratios were the same mice that exhibited the lowest percent of 
pro-B cells expressing RAG2-GFP.  Taken together, our analyses of both the NG 
transgenic and RAG2-GFP knock-in mice indicate that the reduction in numbers of pre-B 
cells is correlated with reduced rag2 expression in pro-B cells.   
 
 
rag2 expression, V(D)J recombinase activity, and the pre:pro ratio are reduced in 
aged mice. 
V(D)J recombinase activity can be demonstrated in live cells using H2-SVEX 
transgenic mice which carry a fluorescent V(D)J recombination reporter substrate (82).  
Cells that undergo V(D)J recombination of the transgene express VEX , a spectrally-
distinct variant of GFP (104, 126),  and are easily detected by flow cytometry.  In 
addition, the percent of VEX+ cells within a population reflects the level of rag 
expression (82).  We crossed NG transgenic mice to H2-SVEX mice to generate double 
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transgenic mice (C57BL/6 background) in which rag2 expression could be measured in 
conjunction with V(D)J recombinase activity.  Figure 4A displays expression of GFP and 
VEX in live pro-B cells from wild type (C57BL/6), NG transgenic, H2-SVEX transgenic 
and NG x H2-SVEX double transgenic mice.  Cells expressing either fluorescent reporter 
are clearly resolved from each other and from non-expressing cells.  GFP is clearly 
detected in NG and double transgenic mice, but not in wild type or H2-SVEX mice.  
Also, VEX is clearly detected in H2-SVEX and double transgenic mice, but not in wild 
type or NG mice. 
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FIGURE 4. Rag2 expression, V(D)J recombinase activity and the pre:pro ratio are 
reduced in aged mice.  (A) Simultaneous flow cytometric analysis of reporters for both 
RAG2 expression and recombinase activity. NG x H2-SVEX double transgenic mice 
were generated in which GFP serves as a reporter of RAG2 expression and VEX serves 
as a reporter of V(D)J recombinase activity.  Bone marrow from wild type, NG 
transgenic, H2-SVEX transgenic and NG x H2-SVEX double transgenic mice were 
stained with antibodies to IgM, B220 and CD43. GFP and VEX expression in pro-B cells 
(IgM-B220+CD43+) are displayed. The numbers within each gate reflect the percent of 
displayed cells within the gate.   The dotted line depicts the gate used to define GFP 
expression, and the solid line depicts the gate used to define VEX expression.  The VEX 
gate is drawn based on the expression of VEX in the H2-SVEX transgenic compared to 
the NG transgenic; the gate is non-rectangular so as to exclude the bright “GFP-only” 
cells that cannot otherwise be accurately excluded in the analysis of VEX in the double 
transgenic mice due to the limitations of flow cytometric compensation correction.  (B) 
Bone marrow was harvested from wild type, CD45.2 young (three to four months at time 
of harvest) and aged (23-29 months at time of harvest) recipient mice five to six weeks 
after adoptive transfer of bone marrow from NG x H2-SVEX double transgenic CD45.1 
mice.  Pro-B (IgM-B220+CD43+), and pre-B cells (IgM-B220+CD43-) of donor origin 
were identified based on expression of CD45.1.  The left and middle panels display the 
mean, standard deviation and distribution of the percent of donor origin pro-B cells that 
are GFP+ and VEX+ respectively.  The right panel displays the mean, standard deviation 
and distribution of the pre:pro ratio.  The pre:pro ratio was calculated by dividing the 
percent of bone marrow that was pre-B cells by the percent that of bone marrow that was 
pro-B cells for each recipient mouse.  Y denotes young mice, A denotes aged mice. 
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Because rag2 is essential for V(D)J recombination, the reduction in rag2 expression 
in aged mice may result in a corresponding decrease in V(D)J recombinase activity.  
Alternatively, it was possible that the reduction in rag2 expression is not of sufficient 
magnitude to affect V(D)J recombinase activity and that other age-related defects 
actually restrict B cell development.  We addressed this by using NG x H2-SVEX double 
transgenic mice and adoptive transfers into young and aged mice.  This provided two 
advantages: 1) we were able to isolate effects of the aged bone marrow 
microenvironment independent of cell-intrinsic defects and 2) this was an expedient 
alternative to aging double transgenic mice.  NG mice were back-crossed on to the 
C57BL/6 background for six generations were mated to H2-SVEX mice.  Whole bone 
marrow from young NG x H2-SVEX CD45.1 double transgenic mice was transferred 
into young (3 months) and aged (28 months) C57BL/6 CD45.2 lethally-irradiated 
recipient mice.  Five to six weeks after transfer we compared rag2 expression and V(D)J 
recombinase activity in donor-derived pro-B cells and the pre:pro ratio of donor-derived 
cells.  Pro- and pre-B cells derived from transferred hematopoietic stem cells or very 
early progenitors present in the transferred marrow were identified based on expression 
of CD45.1. 
 
The percent of donor-derived pro-B cells that express rag2 was significantly lower in 
aged recipients as compared to young recipients (mean = 37 +21 versus 71+5.1; p<0.001; 
Figure 4B and Table 3A). This reduction is comparable to the reduction we observed in 
the NG transgenic (Figure 2 and Table 1) and RAG2-GFP knock-in mice (Figure 3 and 
Table 2). In addition, V(D)J recombinase activity,  as indicated by the percent of pro-B 
cells that are VEX+, was  also significantly lower in pro-B cells from aged recipients  as 
compared to young recipients (mean = 17+6.4 versus 33+4.8; p<0.001;  Figure 4B and 
Table 3A). This is the first analysis of V(D)J recombinase activity in pro-B cells in aged 
mice and it suggests that the reduction in rag2 expression in pro-B cells of aged mice is 
sufficient to result in reduced V(D)J recombinase activity.  
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TABLE 3.  Statistical Analysis of Data Obtained from Young and Aged C57BL/6 
Recipient Mice Following Adoptive Transfer of NG x H2-SVEX Transgenic Bone 
Marrow. 
 
A.  Significance of Differences Between Young and Aged Groups 
   young       aged p-value 
% of donor pro-B cells that are GFP+ 71  + 5.1  37    + 21 <0.001  
% of donor pro-B cells that are VEX+ 33  + 4.8  17    + 6.4 <0.001  
Pre:pro ratio 3.2 + 0.56  0.66 + 0.56 NA 
Log of pre:pro ratio 1.1 + 0.18 -0.83 + 1.0 <0.001 
 
 
B.  Correlation Between Characteristics, All Mice (n = 30) 
  
LN pre:pro ratio 
% of pro-B cells 
that are GFP+ 
% of pro-B cells 
that are VEX+ 
Log pre:pro ratio  r=0.812  p<0.001 r=0.860  p<0.001 
% of pro-B cells that are GFP+ r=0.812  p<0.001  r=0.835  p<0.001 
% of pro-B cells that are VEX+ r=0.860  p<0.001 r=0.835  p<0.001  
 
 
C.  Correlation Between Characteristics, Aged Mice (n = 17) 
  
LN pre:pro ratio 
% of pro-B cells 
that are GFP+ 
% of pro-B cells 
that are VEX+ 
Log Pre:pro ratio  r=0.550  p=0.022 r=0.670  p=0.003 
% of pro-B cells that are GFP+ r=0.550  p=0.022  r=0.634  p=0.006 
% of pro-B cells that are VEX+ r=0.670  p=0.003 r=0.634  p=0.006  
 
(n = number of mice, r = correlation coefficient, p = significance,  NA = not applicable  
as distribution is not normal). 
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TABLE 3.  Statistical Analysis of Data Obtained from Young and Aged C57BL/6 
Recipient Mice Following Adoptive Transfer of NG x H2-SVEX Transgenic Bone 
Marrow. 
Analysis of the young and aged C57BL/6 recipient mice from Figures 3 and 4.  (A) The 
mean, standard deviation and significance of differences in means between young and 
aged mice groups are shown.  (B) The correlations between traits within all mice 
(included young and aged) are shown.  (C) The correlations between traits within the 
aged mice are shown. 
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In addition, we analyzed the pre:pro ratio of CD45.1+ donor-derived cells as a 
measure of pre-B cell numbers in the young and aged adoptive transfer recipients.  We 
used the pre:pro ratio because absolute numbers of donor derived cells were not 
comparable between mice due to variation in degree of engraftment in individual mice.  
The donor pre:pro ratio was lower in the aged recipient mice as compared to the ratio in 
young recipient mice (mean = 0.66 + 0.56 versus 3.2 + 0.56).  Because the ratios did not 
have a normal distribution, we conducted a student’s t-test on the log (LN) ratios, which 
were normally distributed.  The mean log ratio was significantly lower in aged recipient 
mice than in young recipient mice (mean = -0.83 + 1.0 versus 1.1+0.18; p<0.001; Table 
3A). 
 
The age-associated reduction in rag2 expression, V(D)J recombinase activity in 
pre:pro ratio might  be the result of independent age-associated defects or these could be 
interrelated.  To address this, we conducted statistical analyses to determine if these traits 
were correlated in the population of mice as a whole (n=30), and if these correlations 
were also observed if the analysis was restricted to the aged recipient mice (n=17). As 
reported in Table 3B and C, all three parameters (the percent of pro-B cells that were 
GFP+, the percent of pro-B cells that were VEX+ and the pre:pro ratio) were correlated in 
both the entire population of mice (n=30) and in the aged group (n=17).  These 
correlations are also apparent when individual aged mice are examined for each 
parameter: mice with extensive reduction in rag2 expression in pro-B cells also had an 
extensive loss of V(D)J recombinase activity in pro-B cells, and significant reduction of 
the pre:pro ratio (data not shown). In contrast, mice that had a minor reduction in rag2 
expression also had only minor reductions in V(D)J recombinase activity and the pre-pro 
ratio. 
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The bone marrow microenvironment controls rag2 expression and V(D)J 
recombinase activity in pro-B cells and the pre:pro ratio. 
The use of an adoptive transfer model also enabled us to determine if the age-
associated defects in B cell development are due to changes in the hematopoietic 
microenvironment of the bone marrow or due to changes that are cell–intrinsic.  We 
observed that donor-derived pro-B cells displayed lower rag2 expression and V(D)J 
recombinase activity and there was a lower pre:pro ratio following bone marrow transfer 
into aged  as compared to young recipient mice (Figure 4).  This was observed for 
transferred cells from young donor mice, thus indicating that age-associated alterations 
specific to the bone marrow microenvironment are sufficient to produce these defects in 
B cell development.  
 
Young bone marrow microenvironment restores rag2 expression and the pre:pro 
ratio. 
The presence of defects in B cell development due to changes in the bone marrow 
hematopoietic microenvironment does not preclude the existence of age-related, cell-
intrinsic defects in B cell development.  To determine if cell-intrinsic defects affect rag2 
expression in pro-B cells, and the pre:pro ratio, we conducted adoptive transfer 
experiments in which bone marrow from aged and young donor mice was transferred into 
young recipient mice.  The NG mice shown in Figure 2 (four of the six young and all of 
the aged) were used as sources of bone marrow for adoptive transfer into lethally 
irradiated young, wild type recipient mice.  Donor bone marrow was not pooled in this 
experiment; each recipient mouse received an adoptive transfer from either a young or 
aged donor.  Using this experimental design, progenitors from young and aged mice were 
evaluated after differentiation within the same microenvironment; the bone marrow of a 
young recipient. 
 
Prior to adoptive transfer all five of the aged donor mice displayed significantly) 
lower pre:pro ratios than those of the young donor mice (mean = 1.7+0.94 versus 
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3.7+0.41;  p=0.006; Figure 5A and Table 4A). The percent of pro-B cells that express 
rag2 was also significantly lower in the five aged donor mice than in the young donor 
mice (mean = 45+19% versus 75+2.5%; p= 0.023; Figure 5B and Table 4A). 
A Young and aged intact donor mice
B
Young recipient mice following adoptive transfer
Y1   Y2    Y3    Y4    A1    A2    A3    A4   A5
FIGURE 5. Pro-B cells derived from young and aged sources display similar
rag2 expression and pre:pro ratios in young hosts. 
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FIGURE 5.  Pro-B cells derived from young and aged sources display similar rag2
expression and pre:pro ratios in young hosts.  Bone marrow from young (3 months) 
and aged (26-27 months) NG mice were transferred into lethally irradiated young (2 
months at time of transfer) recipient mice.  (A) GFP expression in pro-B cells (left panel) 
and pre:pro ratio (right panel) in young and aged donor mice at time of transfer.  These 
mice are four of the six young, and all of the aged mice shown in Figure 2.  To aid 
comparisons, each young mouse is given a designation, Y1-Y4, and each aged mouse 
A1-A5, depicted between the two panels. (B) Bone marrow harvested from young 
recipient mice five weeks after transfer of bone marrow from either a young or aged 
donor.  Pro-B cells were defined as IgM-B220+CD43+AA4.1+, pre-B cells were defined 
as IgM-B220+CD43-AA4.1+CD24++.  The percent of pro-B cells that are GFP+ and the 
pre:pro ratios are shown.  The pre:pro ratio of two young intact NG mice used as controls 
in this experiment were 1.2 and 1.3.  The designations Y1-Y4 and A1-A5 reflect the 
source of the transferred bone marrow as shown in A.
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TABLE 4.  Statistical Analysis of Data Obtained from Cells Harvested from Donor 
Mice and Recipient Mice Following Adoptive Transfer of NG Transgenic Bone 
Marrow. 
Analysis of the young and aged donor mice from Figure 4A are displayed.  (A) The 
mean, standard deviation and significance of differences in means between young donors 
and aged donor mice are shown. Data is from four of the six young mice displayed in 
Figure 2 (the mice that served as donor mice for adoptive transfer). (B) Analysis of the 
young adoptive transfer recipient mice from Figure 4B are shown. 
 
A.  Comparisons of Bone Marrow from Young and Aged Donor Mice 
   young    aged p-value 
Pre:pro ratio 3.7 + 0.41 1.7 + 0.94  0.006 
Percent of pro-B that are GFP+ 75  + 2.5 45  + 19  0.023 
 
 
 
B.  Comparisons of Bone Marrow from Young Recipient Mice Following Adoptive 
Transfer of NG Transgenic Bone Marrow from Young or Aged Donors 
 from young donor from aged donor p-value 
Pre:pro ratio       1.7 + 0.58     1.7 + 0.40   NS 
Percent of pro-B that are GFP+       82  + 9.8     82  + 9.3   NS 
 
(n = number of mice, r = correlation coefficient, p = significance, NS = not significant) 
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Five weeks after adoptive transfer, B cell development and rag2 expression in young 
recipient mice was assessed by flow cytometry.  Pro-B cell were defined as IgM-
B220+CD43+AA4.1+ and pre-B cells were defined as IgM-B220+CD43-AA4.1+CD24+.  In 
this experiment a marker of donor cells was not available.  However, efficient 
engraftment must have occurred because 1) recipients survived lethal irradiation, 2) in 
comparable experiments, engraftment in young mice routinely resulted in over 90% pro-
B cells of donor origin, and 3) the expression of GFP in pro-B cells (which clearly 
identifies cells of NG transgenic donor origin) was high (60% - 90% of pro-B cells) in 
bone marrow harvested from recipient mice (Figure 5B). 
 
We found that rag2 expression in young recipient mice was not significantly affected 
by the age of the bone marrow donors (Table 4B).  The percent of pro-B cells that were 
GFP+ was 82+9.8% in mice that received bone marrow from young donors and 82+9.3% 
in mice that received bone marrow from aged donors (Figure 5B and Table 4B).  The 
severity of diminished rag2 expression in pro-B cells of aged donors was not reflected in 
recipient mice.  Of the donors, mouse A3 (Aged #3) displayed the lowest percent of pro-
B cells with rag2 expression, less than 15% (Figure 5A).  In the two young mice that 
received a bone marrow transfer from A3, rag2 was expressed in greater than 70% of 
pro-B cells and was comparable to that of other recipient, young mice (Figure 5B).  
These observations indicate that the reduction in rag2 expression in pro-B cells of aged 
mice is not the result of defects that are intrinsic to the developing cells. 
 
The pre:pro ratios were also compared in young reconstituted mice and were not 
significantly different due to the age of bone marrow donors (Table 4B).  The mean 
pre:pro ratio was 1.7+0.40 in mice that received bone marrow from aged donors, and 
1.7+0.58 in mice that received bone marrow from young donors (Figure 5B and Table 
4B.)  Again, the severity of the age-related defect was not reflected following adoptive 
transfer into young hosts.  Aged donor mice A1, A2 and A3 displayed the lowest pre:pro 
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ratios (Figure 5A), yet the seven young recipients of bone marrow from these mice 
displayed pre:pro ratios that were as high as those observed in mice that received bone 
marrow from other aged, or young, donors (Figure 5B).  This indicates that the age-
related reduction in the pre:pro ratio is not the result of cell-intrinsic defects in 
hematopoietic precursors.  
 
These experiments indicate that rag2 expression and V(D)J recombinase activity in 
pro-B cells and the number of pre-B cells are reduced in aged mice.  The degree to which 
expression of rag2 is reduced is correlated with the severity of loss of V(D)J recombinase 
activity and pre-B cell numbers.  This indicates that these three defects could be the result 
of the same underlying cause or that loss of rag2 expression leads to reduced V(D)J 
recombinase activity and in turn, fewer pre-B cells.  These experiments also show that the 
age-associated changes in the bone marrow microenvironment are sufficient to result in 
loss of rag2 expression and V(D)J recombinase activity in pro-B cells and numbers of 
pre-B cells.  
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DISCUSSION 
B cell development is impaired in aged mice and characterized by fewer pre-B cells 
and reduced expression of rag1 and rag2 in total bone marrow (90, 97, 98, 101, 113).  
Prior to this work it was unknown if expression of rag1 or rag2 is lower in pro-B cells.  If 
was also unknown if age-associated defects in B cell development are due to cell-intrinsic 
alterations or changes in the hematopoietic microenvironment.  We have found rag2 gene 
expression is reduced in pro-B cells of aged mice.  The reduction in rag2 expression is 
consistent with reduced V(D)J recombinase activity and reduced numbers of pre-B cells, 
suggesting that the age-related reduction in pre-B cell numbers could be the result of 
diminished rag2 expression. We also show that these defects are due to age-related 
defects in the bone marrow hematopoietic microenvironment as opposed to cell-intrinsic 
defects. 
 
The percent of pro-B cells that express rag2 and display V(D)J recombinase activity 
as measured by the transgenic reporters are reduced in aged mice.  We analyzed B cell 
development in young and aged NG transgenic mice (24, 80) and RAG2-GFP knock-in 
mice (81).  Robust GFP expression in the former system enables characterization of rag2 
expression in small subsets of lymphoid progenitors while the latter system enables real-
time analysis of RAG2 protein.  In both systems we extended the analysis of rag2 
expression in aged mice to show that expression is reduced within pro-B cells of aged 
mice (Figures 2, 3 and 4 and Tables 1, 2 and 3).  An assessment of rag expression at the 
single cell level in pro-B cells has not been done prior to this.  A strength of this approach 
is that we were able to determine that reduced rag2 expression in pro-B cells of aged 
mice is due to a lower percent of pro-B cells that express rag2 as opposed to a lower per 
cell level of expression within all pro-B cells. 
 
It is unlikely that the reduction in GFP in aged transgenic mice is due to specific 
silencing of the transgene.  Our results from the NG transgenic mice are consistent with 
those of the RAG2-GFP knock-in fusion protein mice that is unlikely to be silenced by 
the same mechanisms that silence repetitive transgenic DNA sequences.  In addition, pro-
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B cells generated from precursors from aged NG mice expressed GFP levels similar to 
that of pro-B cells derived from young NG mice following adoptive transfer into young 
host.  This restoration of expression indicates that the transgene was not silenced.  These 
observations indicate that the reduction in GFP expression in pro-B cells of aged mice 
reflect a loss of rag2 expression rather than silencing of the reporter transgene. 
 
We also used H2-SVEX mice to study V(D)J recombinase activity at the single-cell 
level for the first time in aged mice (82).  Using NG x H2-SVEX double transgenic mice 
as donors, we were able to show that V(D)J recombinase activity is reduced in pro-B 
cells of aged mice.  In H2-SVEX transgenic mice, the reporter recombination substrate 
provides a measure of recombinase activity independent of developmentally-regulated 
accessibility of the immunoglobulin loci.  Thus, the reduction in recombination that we 
observed in aged mice is attributable to reduced expression, or activity, of the enzyme 
complex required for V(D)J recombinase activity.  This indicates that the degree to which 
rag2 expression is reduced in pro-B cells of aged mice is of sufficient magnitude to result 
in a decrease of V(D)J recombinase activity.  This supports the hypothesis that reduced 
rag2 expression results in reduced V(D)J recombinase activity, generation of the pre-
BCR and transition of cells into the pre-B cell stage of development.  
 
In addition, we found that the loss of rag2 expression and V(D)J recombinase 
activity in pro-B cells was associated with the reduction in pre-B cell numbers.  
Importantly, aged mice exhibit these traits in association with each other, as shown by the 
correlations between these traits when statistical analysis considered only the aged mice 
(Table 3C).  Aged mice with a moderate decline in rag2 expression also displayed a 
moderate reduction in recombinase activity and pre:pro ratio while in other mice all three 
defects were more pronounced (Figure 4C). This indicates that the reduction of 
transcription of rag2, whose function is required for progression to the pro-B cell 
developmental stage, is correlated with reduced numbers of pre-B cells.  In addition, we 
observed altered distribution of cells within the pro-B cell fraction, as shown by the 
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reduced percent of CD24high cell in aged mice (Table 1). Van der Put et al. (91) recently 
reported that in aged mice that have a severe loss of pre-B cells the percentages of pro-B 
cells in Fr B and C/C’ are lower as compared to young mice.  These observations indicate 
that developmental progression within the pro-B cell stage is impaired in aged mice. 
 
Together these observations indicate that impaired development within the pro-B cell 
stage and reduced generation of pre-B cells contributes to the reduced number of pre-B 
cells in aged mice.  This is consistent with our hypothesis that reduced rag2 expression 
and V(D)J recombinase activity contribute to reduced generation of the Ig heavy chains, 
pre-BCR expression, and progression to the pre-B cell stage of development. 
 
Changes in the bone marrow microenvironment are sufficient to cause the age-
related defects in B cell development. 
One of our aims was to determine if defects in B cell development in aged mice was 
due to changes in the bone marrow hematopoietic microenvironment or to changes in the 
developing precursor cells. We performed complementary adoptive transfer experiments 
to separately evaluate the impact of the aged bone marrow microenvironment and the 
impact of aged precursor cells. 
 
When bone marrow from young mice was transferred into mice of different ages we 
found that the aged bone marrow microenvironment was sufficient to produce reduced 
rag2 expression and V(D)J recombinase activity in pro-B cells as well as reduced pre:pro 
ratio.  In reciprocal experiments, we transferred bone marrow from mice of different ages 
into young hosts and found that rag2 expression in pro-B cells and the pre:pro ratio were 
comparable regardless of donor age.  These experiments indicate that the age-associated 
defects in rag2 expression and V(D)J recombinase activity in pro-B cells and the pre:pro 
ratio are the result of changes in the bone marrow microenvironment rather than cell-
intrinsic alterations.  This does not rule out the existence of other cell-intrinsic alterations 
in B cell development. 
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Reduced pre-B cell numbers are due to impaired development not reduced numbers 
of pro-B cells. 
Earlier studies indicate that the reduction in pre-B cells was not accompanied by a 
reduction in pro-B cells (101).  However, our results, along with other recent papers, 
indicate that numbers of pro-B cells are significantly reduced in aged mice (91, 95, 96).  
The discrepancies are possibly due to differences in strains of mice, or the use of the 
monoclonal antibody AA4.1 to discriminate pro-B cells from other CD43+B220+IgM- 
cells.  Recently it was proposed that the loss of pro-B cells in BALB/c is correlated with a 
severe loss of pre-B cells (91).  The observation that numbers of pro-B cells are reduced 
in aged mice raised the concern that a smaller pool of pro-B cells might alone account for 
the reduction in numbers of pre-B cells.  For this reason, we compared the number of pre-
B cell between young and aged mice using both the absolute numbers of pre-B cells, and 
using the pre:pro ratio.   By both measures the numbers of pre-B cells are reduced in aged 
mice, indicating that a reduction in the size of the pro-B cell pool does not account for the 
total reduction in pre-B cell numbers in aged mice. This is supported by the kinetic 
analysis conducted in the lab of Dr. Michael Cancro that indicates generation of pre-B 
cells is reduced in aged mice (personal communication, Dr. Michael Cancro [addressed in 
Chapter 4 Discussion]). 
 
Potential mechanisms to account for alterations in the pro-B cell stage. 
Factors and signals from bone marrow stromal cells are essential to the survival of 
developing B cell precursors and regulate the expression of transcription factors that 
govern commitment and differentiation of developing B cells.  Cells at the pro-B cell 
stage require both cell-mediated contact and soluble factors.  The stromal-derived factors 
IL-7, flt3L, SDF-1, and SCF are all critical for B cell development [as reviewed in (54)].  
Specific extrinsic factors that induce rag expression have yet to be characterized. It is 
possible that the age-related decrease in rag2 expression in pro-B cells could be due to 
attenuation of inductive signals.   
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Another possible mechanism that would contribute to reduced numbers of pre-B 
cells is decreased signaling through the pre-BCR due to reduced expression of 5 (95).  
5 is a component of the pre-BCR that is essential for developmental progression to the 
pro-B cell stage.  Expression of surface and cytoplasmic 5 is reduced in pro-B cells of 
aged mice (95). 
 
A third potential mechanism for the reduction in number of pre-B cells is reduced 
numbers of, or supportive capacity of stromal cells. We observed in aged mice that the 
percent of pro-B cells that express rag2 is reduced; however, in pro-B cells that do 
express rag2, the per cell level of expression is similar to that of young mice.  This could 
indicate that fewer pro-B cells receive signals and factors from the stromal 
microenvironment, but those that do receive the required factors develop normally.  The 
alterations in pro-B cell development may be due to limited access of precursors to 
reduced numbers of stromal cells.  Future experiments could be done to determine if 
stromal cell numbers are reduced in aged mice. 
 
Reduced rag expression may contribute to restriction of the BCR repertoire. 
Our results indicate that the pro-B cell stage of development is impaired in aged 
mice, resulting in reduced numbers of pre-B cells.  This could contribute to reduced 
diversity of IgH chains, and the Ig repertoire in aged mice.  Previous work has shown that 
receptor diversity is reduced in aged mice and that adaptive immunity is severely 
impaired.   Our observations of reduced rag2 expression and V(D)J recombinase activity 
support a model in which loss of IgH chain diversity results in reduced generation of 
mature naive B cells with novel B cell receptor specificity and thus reduced humoral 
adaptive immunity in aged mice. 
 
Our results show that the documented reduction in pre-B cells occurs simultaneously 
with changes that occur in the pro-B cell stage of development that include reduced rag2 
expression and V(D)J recombinase activity.  Alterations in the aged bone marrow 
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microenvironment are sufficient to produce these defects independent of cell-intrinsic 
alterations. Our work indicates that the loss of rag2 expression and reduced V(D)J 
recombinase activity in pro-B cells and reduced numbers of pre-B cells are due to 
changes in the aged bone marrow microenvironment.  The nature of these changes 
remains to be determined.   
 
The alterations in B cell development in aged mice have similarities to those 
observed in aged humans.  A better understanding of the underlying mechanisms 
responsible for these alterations would enable the design of experiments to address these 
changes in humans.  Ultimately, this could lead to therapeutics that restore B cell 
production and thus the adaptive immune response to both pathogens and vaccines in 
aged humans. 
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CHAPTER III 
 
Bone Marrow B Cell Populations in Aged Mice Are Influenced by Genetic 
Polymorphisms and Associated With Changes in T Cell Subsets 
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† Department of Molecular Genetics and Microbiology, Program in Immunology and 
Virology, University of Massachusetts Medical Center, Worcester, MA 01655 
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INTRODUCTION 
In both humans and mice, the immune system declines with age and is characterized 
by attenuated adaptive immunity, especially in response to new pathogens.  Cellular and 
humoral immunity are both affected.  Changes in cellular immunity include an increase in 
the percent of CD4 and CD8 T cells of the memory phenotype (103, 127-129) and an 
increase in the percent of T cells that display defects in activation (12, 103).  T cell 
development also declines: beginning at maturity, the thymus decreases in size with age.  
In addition, altered T cell selection results in a skewed T cell repertoire (13, 130, 131).  
Changes in humoral immunity include a restricted immunoglobulin repertoire, reduced 
antibody production in response to pathogens and vaccines, and an increase in auto-
reactive B cells (3, 113). B cell production is also impaired in aged mice. Compared to 
young mice, the size of the peripheral mature B cell pool is similar, but the rate of turn-
over is greatly reduced and the rate at which cells enter the pool is lower (9). 
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During B cell development pluripotent hematopoietic progenitors progress through 
an ordered series of stages and develop into mature B cells.  The stages of B cell 
development are defined by acquired characteristics that include expression of lineage-
specific genes, immunoglobulin (Ig) gene rearrangement and expression of cell surface 
antigens (18, 123).  As precursor B cells develop in the bone marrow they progress from 
hematopoietic stems cells through Common Lymphoid Progenitors (CLP), pro-B 
(B220+CD43+IgM-), pre-B (B220+CD43+IgM-), and immature B cell (B220+CD43-IgM+) 
stages of development prior to export to the spleen (18, 123). 
 
 The most pronounced change in B cell development in aged mice is the reduction in 
numbers of pre-B cells, as aged mice can have as few as 10% of the number of pre-B 
cells found in young mice (90, 91, 95, 97, 101, 132, 133), this is also observed in Chapter 
2. There is also an age-associated reduction in numbers of pro-B cells (91, 96).  In 
contrast, the number of re-circulated mature B cells in the bone marrow initially increases 
with age (9, 91, 132) but declines as the age-related defects in B cell development 
become progressively worse with age (91).  The mechanism(s) underlying these 
alterations in aged mice are unknown and may be multi-factorial. 
 
Reduced transition of cells from the pro-B to pre-B cell stage of development may be 
critical to the reduced number of pre-B cells in aged mice.  The developmental 
checkpoint between the pro- and pre-B cell stages requires assembly and signaling 
through the pre-BCR composed of the Ig heavy chain (IgH), 5 and VpreB.  Synthesis of 
the IgH chain occurs in the pro-B cell stage of development and requires expression of 
rag1and rag2 to mediate V(D)J recombination of IgH genes. We have found that rag2 
expression is reduced within pro-B cells in aged mice and this reduction is correlated 
with both a reduction in V(D)J recombinase activity and diminished numbers of pre-B 
cells (Chapter 2 and Labrie et al. in preparation).  A second mechanism to account for 
reduced numbers of pre-B cells is the age-related reduction in 5 expression (95, 100).  
Reduced 5 may limit the efficiency with which the pre-BCR transmits signals required 
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for progression to the pre-B cell stage. Both findings point to a limitation at the pro-B to 
pre-B cell transition. 
 
 One approach to understanding the mechanism(s) responsible for diminished B cell 
generation with age is to identify specific genes that influence B cell development in an 
age-dependent manner. As a first step towards this goal, we proposed that genetic 
polymorphisms in different mouse strains might influence the pace at which age-specific 
alterations in B cell development occur with advancing age and/or the severity of these 
changes. These polymorphisms could occur in genes that are expressed in developing B 
cells, in bone marrow stromal cells required to support B cell generation, or alternately in 
peripheral T cells that in turn might influence B cell development.  As an initial step in 
characterizing the genetic influences on age-sensitive B cell developmental pathways, we 
used a genome scan approach to determine if polymorphisms between different mouse 
strains are associated with age-related changes in B cell development in a large cohort of 
genetically heterogeneous mice. 
 
This cohort (termed UM-HET3) was produced by mating BALB/cJ x C57BL/6J F1 
females and C3H/HeJ x DBA/2J F1 males.  The four progenitor inbred strains were 
chosen for several reasons, including their relatively substantial interstrain genetic 
variation (105).  Variation at simple sequence length polymorphism sequences (SSLP) 
have been successfully used to identify QTL associated with lifespan (Jackson et al., 
2002), age-related T cell phenotypes (Jackson et al., 1999; Miller et al., 2003),  frequency 
of splenic B cells (134),  and other quantitative phenotypes (135).  We expected this 
cohort to display diversity with respect to age-related alterations in B cell development 
and thus enable us to determine if genetic polymorphisms between these strains are 
associated with specific differences in the age-related changes in B cell development. 
 
We also wanted to determine if correlations exist in the aged cohort between pre-B 
cell frequencies and other lymphocyte populations. The use of aged genetically 
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heterogeneous mice enabled us to determine if altered frequencies of B cell precursor 
subsets were correlated with age-associated increases in mature re-circulated B cells in 
the bone marrow or with age-associated alterations in peripheral T cell subsets.  
 
Here we report that the frequencies of both pre-B cells and re-circulated bone 
marrow B cells in aged mice are linked to specific genetic polymorphisms.  In addition, 
we show that the early stages of B cell development, pro- and pre-B cells, are not 
correlated with the frequency of peripheral memory and anergic T cells subsets nor 
mature re-circulated B cells in the bone marrow.  Instead, we found that pro- and pre-B 
cell frequencies were inversely correlated with the frequency of B220intIgMlo cells in the 
bone marrow.  Furthermore, we found that the frequencies of both re-circulated B cells 
and B220intIgMlo cells are correlated with the frequencies of anergic and memory 
peripheral T cell subsets.  These observations indicate that it is feasible to identify 
polymorphisms in mice that influence the effect of aging on B cell development.  In 
addition, this work furthers our understanding of the relationships between peripheral T 
and B cells and B cell development in aged mice.  The extension of these observations 
may lead to better understanding of the genetic basis of age-related changes in B cell 
development. 
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MATERIALS AND METHODS 
Mice generation and husbandry  (conducted at University of Michigan) 
This study utilized a genetically heterogeneous mouse population, denoted UM-
HET3 that was derived from four inbred strains: BALB/cJ(C), C57BL/6J(B6), 
C3H/HeJ(C3), and DBA/2J(D2).  The experimental animals were the female progeny of 
(C x B6)F1 females and (C3 x D2)F1 males.  This breeding scheme produces mice that 
are genetically distinct but can be considered full siblings.  The F1 breeding animals were 
purchased from the Jackson Laboratories (Bar Harbor, ME).  Throughout the study, all 
mice were housed in a single suite of specific-pathogen free (SPF) rooms under identical 
environmental conditions (12:12 hour light:dark cycle, 23°C) and given ad libitum access 
to water and laboratory mouse chow. Quarterly tests of sentinel mice showed that the 
facility remained SPF throughout the study (136).  Blood samples were obtained by 
venipuncture at ages 4, 12, and 15 months.  At six months of age an abdominal skin 
biopsy was obtained under brief methoxyfluorane anesthesia.  In addition, a tail clip was 
taken at 1 to 2 month for DNA analysis.  The animals were humanely euthanized at 18 
months of age.  Bone marrow specimens were removed by flushing from tibias, and sent 
by overnight courier from the University of Michigan to the University of Massachusetts 
for analysis.   
 
Genotyping (conducted at University of Michigan) 
Genotyping was performed by standard polymerase chain reaction (PCR) 
amplification of genomic DNA from each animal.  The PCR amplified DNA was 
genotyped using an ALFexpress automated sequence analyzer (Pharmacia, Piscataway, 
NJ); the details of this genotyping method have been described previously (7).  Primer 
pairs were purchased from MWG Biotech Inc. (High Point, NC).  In total, 185 markers 
were examined from 99 genetic loci. Of the 99 loci, 86 markers were informative for both 
the maternal and paternal derived alleles and 13 loci were only informative for maternal 
or paternal.  Genetic loci were initially selected using data provided by the Mouse SSLP 
Database, Whitehead/MIT Center for Genome Research (137); Cambridge, MA; 
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http://www.genome.wi.mit.edu/cgi-bin/mouse/) or the Mouse Genome Database 3.1, 
Mouse Genome Informatics, the Jackson Laboratory (http://www.informatics.jax.org/).  
Loci were chosen that were polymorphic among the four inbred strains and were 
distributed across the genome (15 to 20 cM intervals).  The final 99 loci were selected 
based on their ability to be amplified by PCR and viewed on the gel electrophoresis 
system reproducibly and easily.  Chromosomal localization and order of markers were 
calculated using the MapManager QTX program package (138). 
 
Statistical analysis (conducted at University of Michigan) 
A single point genome-wide search was performed for each trait in order to detect 
QTLs that may be associated with the trait.  To make the analysis consistent for all 
partially and fully informative markers, 4-way informative markers were split into two 
sets of bi-allelic markers, informative for either the maternally or paternally transmitted 
alleles.  One-way analysis of variance models, with a trait as the dependent variable and a 
bi-allelic marker as the factor with two levels, were used to perform genome-wide 
searches for all 185 bi-allelic markers.  The strength of linkage associations between 
genetic markers and mechanical traits was evaluated using a permutation-based test of 
statistical significance.  This test generates an “experimentwise” acceptance criterion to 
take into account the multiple hypotheses that were tested in this search and to avoid type 
I error inflation (139). A null distribution for permutation analysis was generated based 
on 1000 shuffles of original phenotype data.  An experimentwise p  0.05 was considered 
statistically significant.   The percent of variance in each mechanical trait that can be 
explained by genetic effects was estimated in a standard way from corresponding 
regression models. 
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FACS analysis of bone marrow (conducted at University of Massachusetts) 
Cells were suspended in staining media [RPMI 1640 deficient for biotin, flavin, and 
phenol red (Irvine Scientific, cat # 9826, Santa Ana, CA), with 10 mM HEPES pH 7.2, 
0.02% sodium azide, 1 mM EDTA and 3% newborn calf serum].  Cells were washed and 
suspended at 3 x 107/ml in staining medium and treated for 10 minutes on ice with 
purified antibody (2.4G2) to block Fc receptors. Cells were incubated with primary 
antibodies for 20 minutes followed by three washes, then incubated with streptavidin-Cy5 
-PE for 15 minutes, followed by three washes.  Primary antibodies were anti-IgM-FITC, 
anti-CD43-PE, and anti-B220-Biotin.  Cells were re-suspended in staining medium with 
propidium iodide (1g /ml) to exclude dead cells.  Flow cytometry was performed on a 
FACSCaliber (BDIS).  Dead cells were excluded from analysis thought the use of 
propidium iodide.  Data was analyzed with FlowJo Software (Tree Star, Inc). 
 
FACS analysis of T cell subsets (conducted at University of Michigan) 
Two color flow cytometry analyses were conducted as previously described (140) on 
samples of peripheral venous blood obtained at 8 and then again at 18 months of age.  
Table 5 shows the definition of the four T cell subsets that were reported in this study.   
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TABLE 5.  T Cell Subsets Tested in 8- and 18-Month Old UM-HET3 Mice 
 
Subset Designation Description Calculation 
CD4M Memory CD4 cells CD4+,CD44high as % of CD4 
CD8M Memory CD8 cells CD8+,CD44high as % of CD8 
   
CD4P P-glycoprotein-positive CD4 
cells 
CD4+, R123-extruding as % of CD4 
CD8P P-glycoprotein-positive CD8 
cells 
CD8+, R123-extruding as % of CD8 
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Measurement of T cell proliferation (conducted at University of Michigan) 
Total numbers of nucleated cells were counted at necropsy using a hemocytometer.  
Mice with total spleen cell numbers less than 1.5 x 108 were included in analysis of 
spleen cellularity and T cell functional outcomes.   
 
Immunizations and antibody response  (conducted at University of Michigan) 
Mice were immunized with 5 x 108 sheep erythrocytes in 0.2 ml of saline at 4 
months of age, and with 109 turkey erythrocytes at 15 months of age.  Serum was 
obtained by tail venipuncture at 2 weeks after immunization and assayed for anti-
erythrocyte antibody titer by hemagglutination starting with a 1:16 serum dilution. 
 
Exclusion criteria 
Bone marrow analyses were conducted on 275 mice.  Of these, 224 had genotypic 
data available for D19Mit41 and 203 had genotypic data available for marker 
D15Mit100. Missing values are the result of errors in DNA preparation or ambiguous 
typing results.
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RESULTS 
Analyses of bone marrow B cell populations in aged UM-HET3 mice 
A cohort of 275 female UM-HET3 mice derived from mating BALB/cJ x C57BL/6J 
F1 females and C3H/HeJ x DBA/2J F1 males was generated and aged. DNA was 
obtained from each mouse for genotyping and used to evaluate 87 SSLPs, 77 of which 
discriminate between all four parental strains.  SSLPs were revealed by PCR that detects 
strain differences documented in the Mouse Simple Sequence Length Polymorphism 
Database, Whitehead/MIT Center for Genome Research (carbon.wi.mit.edu:8000/ftp 
/distribution/mouse_sslp_releases/may99) (137). Mice were immunized at four months of 
age with sheep red blood cells and at 15 months of age with turkey red blood cells as part 
of a separate study.  At 18 months of age mice were euthanized and evaluated for several 
aspects of T and B cell immune status.  We used FACS analysis to determine the 
frequencies of pro-B (IgM-B220+CD43+) and pre-B cells (IgM-B220+CD43-) in the bone 
marrow of UM-HET3 mice (Figure 6). Both pro- and pre-B cell frequencies were 
normally distributed among the 275 mice tested (data not shown). 
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FIGURE 6. Flow cytometric analysis of B cell subsets in bone 
marrow of aged UM-HET3 mice. 
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FIGURE 6.  Flow cytometric analysis of B cell subsets in bone marrow of aged UM-
HET3 mice.  Bone marrow from a representative aged UM-HET3 mouse was stained 
with antibodies to IgM, B220 and CD43 for flow cytometric analysis.  Labels above each 
graph indicate the type of cells displayed.  The number within or near each gate reflects 
the percent of cells within the gate.  The upper left panel depicts forward scatter and IgM 
expression in whole bone marrow.  The upper right panel depicts detection of pro-B 
(IgM-B220+CD43+) and pre-B (IgM-B220+CD43-) cells in the IgM- subset.  The lower 
left panel depicts detection of B220highCD43- re-circulating B cells in whole bone 
marrow.  The lower right panel depicts detection of B220intIgM+ cells in whole bone 
marrow. 
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We also measured the frequency of mature re-circulated B cells, as estimated by the 
fraction of cells with the B220highCD43- phenotype (see Figure 6, lower left panel); the 
frequency of these cells increases in aged mice (9, 91, 132). We also noticed that a subset 
of aged mice had an increased frequency of B220intIgM+ cells in their bone marrow.   The 
mean frequency of B220intIgM+ cells in the marrow of aged UM-HET3 mice was 1.1% 
(see Figure 6, lower right panel for an example) and eight mice had frequencies 
exceeding 3%.  These cells are rare in un-immunized young mice and have characteristics 
of early stage memory cells (141).  Because the distribution of the B220intIgM+ subset 
was not normal, we used the log of the number of B220intIgM+ cells, which was normally 
distributed, for our statistical analyses.   
 
QTL Analysis of B cell subsets  
A genome scan was used to determine if genetic polymorphisms among the four 
inbred grandparental strains of mice influenced the frequency of B cell subsets in the 
bone marrow of aged UM-HET3 animals.  Two quantitative trait loci reached 
experimentwise significance levels, and these are listed in Table 6.  We found that the 
frequency of pre-B cells is modulated by a locus linked to SSLP marker D19Mit41 on 
chromosome 19 with p = 0.004.  Of 95 mice that inherited the C57BL/6J SSLP at 
D19Mit41, the frequency of pre-B cells was 9.8 + 4.3% (mean ± SD).  Of 108 mice that 
inherited the BALB/cJ SSLP, the frequency of pre-B cells was 7.4 + 3.8%.  Histograms 
depicting the frequency of pre-B cells in mice differing in their D19Mit41 allele are 
shown in Figure 7. 
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7.4 + 3.8%
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3.9 + 1.8%
4.8 + 1.8%
Re-circulated B cells   
BALB
B6
BALB  
B6
FIGURE 7. Correlations of genomic markers polymorphic between 
C57BL/6J or BALB/cJ mice with the frequency of pre-B cells (IgM-
B220+CD43-) and the frequency of re-circulated B cells (B220hiCD43-) in the 
UM-HET3 aged mouse cohort
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FIGURE 7. Correlations of genomic markers polymorphic between C57BL/6J or 
BALB/cJ mice with the frequency of pre-B cells (IgM-B220+CD43-) and the 
frequency of re-circulated B cells (B220hiCD43-) in the UM-HET3 aged mouse 
cohort. (A) D19Mit41 is correlated with the frequency of pre-B cells. The distribution, 
mean and standard deviation of the percent of pre-B cells in whole bone marrow are 
shown for aged mice which tested positive for either the C57BL/6J or BALB/cJ specific 
allele of the D19Mit41 SSLP.  (B) D15Mit100 is correlated with the frequency of re-
circulated B cells. The distribution, mean and standard deviation of the percent of 
B220hiCD43- cells in bone marrow are shown for aged mice which tested positive for 
either the C57BL/6J or BALB/cJ specific allele of the D15Mit100 SSLP.
 90 
TABLE 6.  Associations between frequencies of B cell subsets in the bone marrow 
and genetic markers. 
The table shows B cell developmental subsets and correlated genomic markers; (a) 
position from centromere in centimorgans; (b) position from centromere in millions of 
base pairs; (c) experiment-wise p-value from permutation test; (d) percentage of 
phenotypic variation attributable to the allelic difference indicated. 
 
 
Trait 
 
Marker 
Position (cM)  
(a) 
Position 
(mpb) (b) 
P< 
(c) 
Allele 
order 
% Effect 
(d) 
Pre-B D19Mit41 16 18 0.004 B6 > BALB/c 8.5% 
B220highCD43- D15Mit100 21 51 0.03 B6 > BALB/c 5.7% 
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The frequency of mature re-circulated B cells was influenced by a gene on 
chromosome 15 linked to the SSLP marker D15Mit100 at a significance level p < 0.03 
(Table 6).  Of the 127 mice that inherited the C57BL/6J SSLP at D15Mit100, the 
frequency of re-circulated cells was 4.8 + 1.8%.  Of the 97 mice that inherited the 
BALB/cJ SSLP, the frequency of re-circulated B cells was 3.9 + 1.8%.  Histograms 
depicting the frequency of re-circulated B cells based on inheritance of the D15Mit100 
genomic marker are shown in Figure 7. 
 
Parallel analyses found no significant evidence for QTL modulating the frequencies 
of pro-B cells and B220intIgM+ cells in this mouse population.   
 
Frequencies of pro- and pre-B cells are not correlated with peripheral T cell subsets, 
but they are inversely correlated with the frequency of B220intIgM+ cells. 
Analysis of the UMHET-3 aged cohort also afforded the opportunity to determine 
whether correlations exist among the various age-sensitive B cell subsets and indices of T 
cell immune status including T cell subset levels and hemagglutination results.  We 
therefore, as a preliminary exploration, examined a correlation matrix to seek evidence 
for relationships that might deserve further attention in later studies.  Table 7 collects 
evidence for correlations among the B cell subsets, and also includes information on 
correlations with antibody responses.  Mice with high levels of pro-B cells tended to have 
high levels of pre-B cells and low levels of the B220intIgM+ subset.  High pro-B cell 
levels, at 18 months of age, were also characteristic of mice that had been able to produce 
high titer anti-erythrocyte antibody at 4 months of age (Table 7), although no such 
correlation was seen when antibody responses were evaluated at 15 months using turkey 
erythrocytes. 
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TABLE 7.  Correlation Coefficients pro- and pre-B cells. 
The table shows correlations among pro-B, pre-B and B220intIgM+ cells and 
antibody response to immunization with sheep RBC.  N = 208-216 mice for each 
calculation, with pairwise exclusion for missing data.  Approximately 40 mice were 
excluded because of splenomegaly (spleen cell number > 150 x 106), but similar 
correlations were noted when these mice were included in the calculations. 
 
PRO-B 
r = 0.37 
(p < 0.0001 ) 
r = -0.22 
(p = 0.0028 ) 
r= 0.21 
(p=0.0023 
r = 0.37 
(p < 0.0001 ) 
PRE-B 
-0.27 
(p < 0.0002) 
r = 0.01 
(p = 0.84) 
r = -0.22 
(p = 0.0028 ) 
-0.27 
(p < 0.0002) 
Log 
B220intIgM+ 
r = 0.05 
(p = 0.45) 
r= 0.21 
(p=0.0023 
r = 0.01 
(p = 0.84) 
r = 0.05 
(p = 0.45) 
Anti-sheep 
hemagglutination 
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Table 8 reports statistics relating B cell subsets to four T cell subsets that rise 
dramatically with age, both in blood and in spleen.  Three of these subsets (the memory 
subsets CD4M and CD8M, and the anergic P-glycoprotein positive subset CD4P, 
measured in peripheral blood) have, in previous work, been shown to predict remaining 
lifespan (142, 143) and thus may serve as biomarkers of aging in the immune system.  
Thus it is noteworthy that the B220intIgM+ B cell population is positively correlated to 
CD4M, CD8M and CD4P in both blood and spleen; five of these six correlations are 
statistically significant at p < 0.02.  The CD8P subset also shows a positive correlation 
for blood T cells, though not for spleen T cells.  Thus high levels of the B220intIgM+ 
subset are seen characteristically in mice whose T cell immune systems resemble those of 
older mice.  The correlations with the B220hiCD43- subset are somewhat less consistent.  
There are significant negative correlations with the CD4P, CD8P and CD4M subsets in 
blood, and with splenic CD4P cells, suggesting that mice with more advanced T cell 
aging tend to have lower levels of marrow B220hiCD43- cells, but the correlations with 
the other four tabulated T cell values are unimpressive.  We found no significant 
correlations between any of these T cell subsets and the pre-B or pro-B levels in bone 
marrow. 
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TABLE 8.  Correlations between T and B cell subsets. 
Each entry shows the Pearson correlation coefficient between the indicated B cell subset 
(left column) and age-sensitive T cell subset (column headers), together with the 
corresponding significance level.  For example, the upper left entry shows R = -0.16 and 
p < 0.01 for the relationship between B220highCD43- marrow B cells and CD4P blood T 
cells.  Boldface highlights entries for which p < 0.05.  N = 254 - 263. 
 
BLOOD 
 CD4P CD8P CD4M CD8M 
B220highCD43- -0.16 (0.01) -0.19 (0.002) -0.18 (0.004) -0.10 (0.1) 
B220intIgM+ 0.09 (0.11) 0.14 (0.02) 0.39 (0.001) 0.23 (0.001) 
 
SPLEEN 
 CD4P CD8P CD4M CD8M 
B220highCD43- -0.20 (0.001) 0.01 (0.8) -0.02 (0.8) -0.01 ((0.8) 
B220intIgM+ 0.18 (0.003) 0.08 (0.2) 0.46 (0.001) 0.24 (0.001) 
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We also evaluated the relationship of these two B cell subsets to splenic T cell 
function as estimated by in vitro proliferation assays.  Mice with high levels of the 
B220intIgM+ subset tended to show high proliferation in responses to anti-CD3 antibody, 
with or without added anti-CD28 antibody (p < 0.005 in each case), but did not show 
significantly higher responses to Con A (data not shown); these correlations may simply 
reflect the ability of anti-CD3 antibody to stimulate proliferation of memory T cells, 
which tend to be higher (Table 8) in mice with high levels of the B220intIgM+ subset.
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DISCUSSION 
One of the key alterations in B cell development in aging mice is the loss of pre-B 
cells.  The extent to which genetic polymorphisms contribute to these age-related changes 
was previously unknown.  Therefore, we undertook a QTL analysis of B cell 
development in a cohort of aged genetically heterogeneous mice.  In addition, a number 
of changes occur in murine lymphocyte populations with age, although it was not known 
if these changes occur independently but parallel to each other or if they are interrelated 
and occur as part of an overall immunosenescence or immunomodulation.  For example, 
thymus involution is parallel to the decline in B cell development, but it is not known if 
these processes are causally related.  Analysis of correlations between these age-related 
changes in a heterogeneous population of mice was undertaken to identify which changes 
occur in conjunction with each other and begin to understand relationships among these 
age-related traits. 
 
Polymorphism on chromosome 19 
We found that the frequency of pre-B cells in the bone marrow is influenced by a 
polymorphism linked to SSLP marker D19Mit41 on chromosome 19.  The frequency and 
number of pre-B cells are reduced in aged mice. Various mechanisms to account for this 
reduction have been proposed, including reduced generation of pre-B cells, increased 
apoptosis of pre-B cells and increased rate of maturation.  We and others have found that 
development within the pro-B cells stage is impaired in aged mice and that fewer pre-B 
cells are produced (9, 90, 91, 96).  In the cohort of aged mice, the frequency of pre-B 
cells was influenced by a polymorphism between BALB/cJ and C57BL/6J mice located 
on chromosome 19, linked to the D19Mit41.  The genomic scan is not of sufficient 
resolution to provide useful information about which specific genes, linked to D19Mit41, 
might be responsible for this phenotype.    It is tempting to speculate that this genetic 
difference has an impact on developmental progression of pro-B cells. The gene on 
chromosome 19 that influences the frequency of pre-B cells in aged bone marrow could 
be expressed in either B cell precursors or in stromal cells that provide essential support 
for B cell development.   Stromal cells from aged mice are less supportive of B cell 
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development than similar cells harvested from young mice (93, 94, 101).  In addition, we 
have found that the decline in pre-B cell frequency, rag2 expression and V(D)J 
recombinase activity in aged mice are all conferred by the aged bone marrow 
microenvironment (as shown in Chapter 2). 
 
Polymorphism on chromosome 15 
The frequency of mature re-circulated B cells in the bone marrow in the aged mouse 
cohort is influenced by a polymorphism linked to SSLP marker D15Mit100 on 
chromosome 15.  Re-circulating bone marrow B cells are mature B cells that resemble 
spleen follicular B cells and the B cells found in lymph nodes and peripheral blood.  
These cells are presumably an important part of immune surveillance and decline of this 
population with age might underlie or reflect compromised mature B cell function. A 
detailed understanding of requirements for B cell trafficking to bone marrow does not 
exist.  However, it is tempting to speculate that this polymorphism could occur in a gene 
involved in B cell homing, either expressed in B cells or in the bone marrow 
microenvironment. 
 
In the case of both polymorphisms  (D15Mit100 and D19Mit41), the impact 
associated with the polymorphism could be age-dependent or age-independent.  In this 
study a QTL analysis was conducted on 18 month old mice.  Bone marrow sampling is a 
terminal assay and for this reason it was not possible to obtain samples from these mice at 
more than one age, although in future work it should be possible to evaluate effects of 
these two QTL on bone marrow B cells of young UM-HET3 mice.  Age-independent 
genomic differences between mice could lead to identification of genes that regulate B 
cell development that are currently unknown.  Age-sensitive genomic differences have 
the potential to increase our understanding of mechanisms of immunosenescence in mice. 
 
Correlations 
Age-associated changes in B cell development occur concurrent with changes in 
peripheral T cell subsets.  We assessed relationships between B cell subsets and 
 98 
peripheral T cell subsets in the aged UM-HET3 cohort to determine if age-associated 
changes were related to each other, to seek initial indications of potential causal 
relationships or common underlying mechanisms.  We found that the frequencies of pro- 
and pre-B cells in the bone marrow are themselves correlated (r= 0.37, p < 0.0001; Table 
7) in the UM-HET3 aged cohort. This correlation is not surprising, as pro-B cells are 
precursors of pre-B cells. We have also observed a significant correlation between the 
frequencies of pro-B and pre-B cells in other experiments involving aged, inbred mice.  
 
In addition to a decline in the number of pre-B cells in aged mice, there is also an 
increase in the number of mature re-circulated B cells in the bone marrow (9, 91, 132).  
The requirements for homing, survival and persistence of mature B cells in the bone 
marrow are not well understood.  It is possible that the increased number of re-circulated 
B cells in the bone marrow competes with developing precursors, therefore resulting in 
attenuated B cell development.  If this were true, we would expect there to be an inverse 
correlation between frequencies of pre-B cells and re-circulated B cells in the bone 
marrow.  However, we did not observe a correlation between re-circulated B cells and 
pre-B cell frequencies in the UM-HET3 aged cohort.  This could indicate that mature B 
cells do not inhibit earlier stages of B cell development or that this effect is not seen as 
early as 18 months of age.  Analysis of pre-B cells and re-circulated B cells in bone 
marrow in inbred strains of mice indicate that the “aged phenotype” occurs more 
frequently in mice older than 18 months of age. 
 
Another age-related change in the immune system is thymic involution, which 
begins shortly after adolescence.  While B cell development is generally regarded as 
independent of T cells, pre-B cell numbers are lower in athymic mice than in age-
matched controls and are partially restored following transfer of syngeneic T cells (97, 
98).  In addition, numbers of pre-B cells are increased in aged and athymic mice 
following injection of supernatant harvested from cultures of CD8+ T cells activated in 
vitro or rIL-16 (97, 98).  These observations support the concept that reduced thymic 
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output of T cells or altered peripheral T cell populations could contribute to lower pre-B 
cell numbers in aged mice.  If this idea is correct, mice with more profound age-related 
alterations in T cell subsets or activation might be expected to suffer greater impairment 
of B cell development.  We evaluated pre-B and pro-B cell numbers in mice differing in 
the frequencies of peripheral T cells subsets known to be increased in aged mice (CD4M, 
CD8M, CD4P and CD8P in blood and spleen).  We also measured activation of splenic T 
cells following in vitro stimulation with anti-CD3 antibodies with or without anti-CD28 
costimulation. We found no correlation between the frequencies of pre-B or pro-B cells 
in the bone marrow and any of the T cell subsets, and no correlation with proliferation of 
splenic T cells.  This lack of correlation suggests that the age-associated reduction in pre-
B cells occur independent of alterations in T cell subsets in aged mice. 
 
Interestingly, the age-sensitive peripheral T cell subsets were, for the most part, 
negatively correlated with re-circulated B cells and positively correlated with 
B220intIgM+ B cells. The frequency of B220intIgM+ cells in the bone marrow was greater 
in mice that had more extensive age-associated changes in T cell subsets (higher 
frequencies of CD4M, CD8M and in both blood and spleen and higher CD4P in spleen, 
and CD8P in blood).  The frequency of B220intIgM+ cells in the bone marrow was 
inversely correlated with the frequency of pro- and pre-B cells (Table 7).  These 
B220intIgM+ cells could be pre-memory plasma cells that have homed to the bone 
marrow.  Further studies would be needed to evaluate whether these cells were elicited in 
response to the immunization at 15 months with turkey RBC. The mice were housed in 
SPF conditions and quarterly serology testing of sentinel mice found no evidence for 
viral infection during the course of these experiments, but we cannot completely exclude 
that increased B220intIgM+ cells could result from encounter with other infectious agents 
or environmental antigens of unknown kinds. These cells might also be activated 
autoimmune B cells.  There is an increase in low affinity auto-reactive antibodies in aged 
mice  (2, 3, 144, 145).  It is possible that advanced T cell decline with age leads to a 
reduction in tolerance to self-antigens, resulting in an increase in activated autoimmune B 
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cells. The relationship of increased frequency of B220intIgM+ cells in the bone marrow 
and autoimmunity deserves further study. 
 
In the UM-HET3 cohort, mice with higher frequencies of B220hiCD43- re-circulated 
B cells in the bone marrow had lower percentages of memory CD4 and CD8 and anergic 
CD4 (i.e. CD4P) cells in blood, and low levels of CD4P cells in spleen (Table 8). These 
observations could indicate that CD4M, CD8M and CD4P cells inhibit production or 
homing of re-circulated B cells to the bone marrow. The frequency of re-circulated B 
cells in the bone marrow initially increases in aged mice (9, 91, 132). However, B cell 
development defects are more extreme at later ages and in mice with severe losses of pre-
B cells (defined as less than 20% of that seen in young mice) also have reduced numbers 
of re-circulated B cells in the bone marrow (91). It is possible that in these mice the 
frequency of re-circulated B cells in the bone marrow is reduced because the production 
of new cells to replace those that are lost is very limited. It would be of interest to 
determine if the correlation between re-circulated B cells and memory and anergic T cells 
is still observed in those conditions. 
 
Summary 
In this work, we show that genetic polymorphisms affect the frequencies of pre-B 
and re-circulated B cells in aged mice.  The refinement of the QTL analysis using a 
higher density of genomic markers and other genetic approaches should permit the 
identification of genes that modulate B cell development in aging. We also show that the 
frequencies of pro- and pre-B cells do not appear to be directly impacted by frequencies 
of peripheral T cells or re-circulated B cells in the bone marrow.  However, pro- and pre-
B cell frequencies are negatively correlated with the frequency of B220intIgM+ cells, a 
subset that is also positively correlated with peripheral T cell memory subsets. 
Furthermore, frequencies of mature re-circulated B cells in the bone marrow are 
negatively correlated with peripheral anergic T cells and CD4 memory T cells in blood.  
This data suggest the “aged immune phenotype” varies greatly in a genetically diverse 
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cohort of 18 month old mice.  In addition, a more advanced aged phenotype might be 
indicated by high levels of anergic and memory T cells, high levels of bone marrow 
B220intIgM+ cells, and low levels of both pre-B cells and bone marrow re-circulated B 
cells. 
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CHAPTER IV 
 
Discussion 
 
4.1 At the start of this work, the mechanisms responsible for loss of pre-B cells in 
aged mice were unknown.  
With age, the immune system in mice and human is attenuated and characterized by 
decreased ability to respond to pathogens, decreased tumor surveillance and increased 
incidence of autoimmunity (1, 2).  Lymphocyte subsets change with age.  The T cell 
population has an increased frequency of memory and anergic cells (1, 2).  And mature B 
cell frequency and numbers increase in the bone marrow of aged mice (3, 9).  Both B and 
T cell populations in aged mice are characterized by increased clonal expansion resulting 
in reduced immunogloblin and TCR receptor diversity (2, 3). 
 
B cells development is reduced in aged mice, and one hallmark of this is a reduced 
number of pre-B cells (9, 90-92, 95, 96, 98, 99, 101, 113, 132).  The mechanism of this 
decline in pre-B cells was not well understood. rag expression was found to be reduced in 
total bone marrow of aged mice (98, 99), however, it was not know if loss of rag 
expression occurred in pro-B cells.  It was also not known if loss of rag expression 
occurs in only the mice with fewer pre-B cells, as there is considerable variability in loss 
of pre-B cells between individual aged mice.  One of the goals of this work was to 
determine if rag expression is lower in pro-B cells of aged mice, and if reduced rag 
expression was correlated with a loss of V(D)J recombinase activity and the number of 
pre-B cells.  These observations would suggest that reduced rag expression contributes to 
the age-associated reduction in pre-B cells.  In addition, it was not known if the aged 
microenvironment or cell-intrinsic defects provide the mechanism responsible for loss of 
pre-B cells.  Nor was if known if genetic differences between strains of mice influence 
the onset or severity of age-associated defects in B cell development. 
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4.2 Determination of factors related to loss of pre-B cells in aged mice. 
Much of the previous research related to diminished B cell development in aged 
mice was centered on comparisons of individual traits between groups of young and aged 
mice.  This approach was informative in identifying age-associated defects.  However, 
there were only limited studies in which the relationships between multiple age-related 
traits were studied.  This approach can be instrumental in suggesting causal relationships 
between different defects.   
 
In this work, I compared the occurrence and severity of multiple physical traits in 
both young and aged mice to identify potential relationships between age-associated 
changes in B cell development and T cells subsets.  Comparisons were made of rag2 
gene expression and V(D)J recombinase activity (Chapter 2), numbers of cells in B cell 
developmental subsets, and frequencies of peripheral T cell subsets (Chapter 3).  In 
addition, the contribution of age-associated defects in the bone marrow 
microenvironment and cell-intrinsic defects were addressed through the use of adoptive 
transfer experiments (Chapter 2).  Finally, QTL analyses were used to determine if 
genetic differences between strains contribute to age-associated defects in B cell 
development (Chapter 3). 
 
4.3 Brief overview of findings 
I found that rag2 expression is lower in pro-B cells of aged mice, and is correlated 
with reduced V(D)J recombinase activity and reduced numbers of pre-B cells (Chapter 
2).  The aged bone marrow microenvironment is sufficient to produce these defects 
(Chapter 2).  In addition, polymorphic differences between C57BL/6 and BALB/c mice, 
located on chromosomes 19 and 15, are associated with frequencies of pre-B and re-
circulated B cells in the bone marrow of 18 month old mice (Chapter 3).  This latter 
finding indicates that genetic differences between strains may contribute to the age-
associated decline in B cell development. 
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Furthermore, I found that the reduced frequency of pre-B cells in aged mice is not 
correlated with the frequency of re-circulated mature B cells in the bone marrow, nor 
with frequencies of peripheral T cell subsets (Chapter 3).  However, frequencies of pro- 
and pre-B cells are inversely correlated with the frequency of B220intIgM+ cells in the 
bone marrow.  B220intIgM+ cell frequency was greater in mice that had more extensive 
age-associated changes in T cell subsets (higher frequencies of CD4 and CD8 memory in 
both blood and spleen and higher frequency of CD4 anergic in spleen, and CD8 anergic 
in blood) (Chapter 3). 
 
4.4 Reduced rag2 expression and V(D)J recombinase activity may contribute to 
reduced generation of pre-B cells in aged mice. 
Before conducting this work, I considered it possible that the reduction in pre-B cells 
in aged mice is due to reduced generation of pre-B cells, increased apoptosis of pre-B 
cells or a decrease in the amount of time for pre-B cells to develop into immature B cells.  
I have shown that in aged mice there are developmental defects within the pro-B cells 
stage of development.  Specifically, there is reduced expression of rag2 and reduced 
V(D)J recombinase activity in pro-B cells of aged mice (Chapter 2).  The reduction in 
rag2 expression was correlated with reduced V(D)J recombinase activity in pro-B cells 
and numbers of pre-B cells, suggesting that reduced rag expression impairs B cell 
development at the pro-B cell stage in aged mice.  These findings indicate that generation 
of pre-B cell may be reduced in aged mice. 
 
It should be noted that the V(D)J recombination reporter substrate used in these 
experiments may actually underestimate the degree to which V(D)J recombinase activity 
is reduced at the endogenous Ig locus in aged mice.  This VEX V(D)J recombination 
substrate reporter is likely to be more efficient than the endogenous loci for two reasons.  
First the reporter was constructed using RSSs of the optimal consensus sequence.  This 
RSS consensus sequence is a more efficient substrate for RAG1 and RAG2 but is not 
actually used at many Ig gene segments.  The murine DH and JH RSSs are not consensus 
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and are in fact far less efficient than those utilized on the substrate (146, 147).  Secondly, 
the sequence of the Ig gene segment that is flanking the RSS (coding ends) makes a 
significant contribution to the efficiency of recombination (148).  The coding ends of the 
VEX substrate contains optimal sequences for recombination.  Thus, the defect in V(D)J 
recombination in pro-B cells from aged mice may be much greater than what the VEX 
substrate may indicate.  Our lab has observed that the substrate is recombined in 25% of 
the pro-B cells of ERAG knock-out mice (compared to 90% of pro-B cells in wt mice), 
whereas recombination of the endogenous Ig locus is severely impaired (at least 5 to 10 
fold) in the ERAG knock-out (21, 82). 
 
Effective V(D)J recombination of Ig genes requires both expression and activity of 
all proteins required for V(D)J recombinase activity and accessibility to the Ig gene 
segments. I have shown that rag2 expression and V(D)J recombinase activity are reduced 
in pro-B cells of aged mice.  The H2-SVEX transgenic mice provide an indicator of 
V(D)J recombinase activity that is independent of Ig gene segment accessibility (82).  
Thus, this work indicates that V(D)J recombinase activity is reduced in age mice, but 
does not address whether an age-associated reduction in Ig gene accessibility might also 
occur in aged mice.  It is possible that both activity and accessibility are reduced.  
Accessibility of 5’ V families of the IgH locus are dependent upon IL-7 signaling (49).  
In aged mice, both production of IL-7 by the stromal cells and responsiveness to IL-7 by 
developing procurers are reduced (93).  Based on these observations, one could predict 
that accessibility to Ig gene segments is reduced in aged mice, however a direct study of 
VH region utilization prior to cellular selection based on BCR affinity has not been 
conducted.  Thus the data presented in Chapter 2 indicating that rag2 expression and 
V(D)J recombinase activity are reduced in aged mice, may understate the degree to which 
V(D)J recombination of Ig genes is reduced in aged mice. 
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4.5 Generation of pre-B cells is reduced in aged mice. 
At the start of this work it was not known if fewer pre-B cells in aged mice were due 
to reduced generation.  The loss of rag2 expression and V(D)J recombinase in pro-B cells 
are indicative of defective development in the pro-B cell stage and support the concept 
that production is limited in aged mice.  Furthermore, my work and that of Van der Put et 
al. (91) show that developmental progression within the pro-B cell stage is attenuated in 
aged mice.  I have shown that the percent of pro-B cells that are CD24high is reduced in 
aged mice.  Van der Put et al. showed that there are reduced numbers of pro-B cells in 
developmental Fractions B and C.  The majority of Fr. C cells have assembled a VDJH 
gene and those that express a pre-BCR begin to undergo proliferation prior to maturation 
to the pre-B cell stage.  Reduced progression into Fraction B and C is also observed in 
rag1 and rag2 KO mice (43, 44).  The defect in developmental progression in aged mice 
and rag KO mice are similar, indicating that a loss of rag expression in aged mice could 
contribute to reduced generation of pre-B cells. 
 
Another potential mechanism that could contribute to reduced generation of pre-B 
cells is reduced 5 expression in pro-B cells of aged mice (95).  5 and VpreB form the 
surrogate light chain, which together with the IgH chain, Ig and Ig form the pre-BCR.  
Pre-BCR signaling is essential for the transition from pro- to pre-B cell stage of 
development. 
 
While our observations and those of Sherwood (reduced 5 expression) provide 
possible mechanisms that would account for reduced generation of pre-B cells, it is work 
from Dr. Michael Cancro that shows pre-B cell generation is reduced in aged mice.  
BRDU labeling experiments show that labeling rates of pro-B cells are similar in young 
and aged mice, indicating a renewal rate of 35-45%, and ~ 2 million cells per day (Table 
9), however, labeling kinetics within the pre-B cell pools of young and aged mice differ 
significantly (Labrie et al. in preparation).  Young adult mice generate 9 to 13 million 
pre-B cells daily and aged individuals produced 2 to 5 million pre-B cells per day (Table 
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9).  The renewal rates of pre-B cells are similar in young and aged mice (32 to 42% per 
day) indicating that the residency time within the pre-B cell stage is unchanged with age 
(Labrie et al. in preparation). The four-fold decrease in generation of pre-B cells 
corresponds well with the degree of pre-B cell loss (loss of cell numbers) in aged mice 
and indicates that reduced generation of pre-B cells is most likely the major contributor to 
reduced pre-B cell numbers in aged mice. 
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TABLE 9.  Production and renewal rates of marrow B cell subsets in Bone 
Marrow Chimeras determined from in vivo BrdU labeling 
 
  Untreated Mice Bone Marrow chimeras 
  
Young Aged 
Young  
Young 
Young  
Aged 
Aged  
Young 
Pro 
Number of 
cells 
(x 10-6) 
3.5  1.3 
2.1  
1.3++§ 
4.0 1.2 2.3  1.3+ 3.2  1.0 
Renewal Rate 
(% of 
pool/day)‡ 
35.8 34.1 31.9 33.0 38.5 
Production 
Rate 
(Cells/day x 
10-6)‡ 
1.2       0.7+ 1.2 0.8 1.4 
       
Pre 
Number of 
cells 
(x 10-6) 
28.0  
9.7 
6.8  
4.3++ 
33.3  10.4 10.0  5.9++ 30.4  12.3 
Renewal Rate 
(% of 
pool/day) 
37.3 32.0 38.0 31.7 35.8 
Production 
Rate 
(Cells/day x 
10-6) 
9.3       2.3++ 10.0 2.2++ 9.5 
       
Immature 
Number of 
cells 
(x 10-6) 
9.3   
3.2 
 7.8  
4.1 
10.9  2.4 4.7   3.5 9.1  4.0 
Renewal Rate 
(% of 
pool/day) 
20 11+ 23.0 17.1 20.7 
Production 
Rate 
(Cells/day x 
10-6) 
2.0       0.8++ 1.5 0.7++ 1.7 
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TABLE 9.  Production and renewal rates of marrow B cell subsets in Bone Marrow 
Chimeras determined from in vivo BrdU labeling. 
Bone Marrow was harvested from young or aged C57BL/6 mice and 3 X 106 T- and 
B-depleted marrow cells were injected i.v. into young or aged (C57BL X DBA2)F1 mice.  
Adoptive hosts were allowed to reconstitute >40 days.  Chimeric bone marrow was 
harvested.  The proportional representation of pro-, pre-, and immature B subsets was 
assessed by FACS, and multiplied by the marrow cell estimate of Osmond (149, 150) to 
obtain total numbers.  Figures given for untreated mice are from young or aged C57BL6. 
‡  BrdU labeling was performed in reciprocal young <-> aged chimeric mice.  The 
proportion of BrdU labeled cells was determined by FACS and the numbers of BrdU 
labeled cells calculated by multiplying these proportions by the marrow cell estimate of 
Osmond (149).  The regression coefficients of absolute and proportional labeling vs. time 
provide estimates of production and renewal rates respectively. 
§  Means were compared (young versus aged or reciprocal chimeras versus control 
chimeras) using student’s t-test.  +, P<0.05;  ++, P<0.01 
 
From Dr. Michael Cancro, University of Pennsylvania, personal communication. 
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4.6 Defects in the aged murine bone marrow microenvironment are sufficient to 
result in defects in B cell development. 
Before completing this work, I considered it likely that both cell-intrinsic defects and 
defects in the bone marrow microenvironment contribute to the age-associated reductions 
in rag expression and numbers of pre-B cells.  In vitro experiments have indicated 
defects in both developing precursors from aged mice and the bone marrow stromal 
microenvironment (93, 94, 101).  However, in vivo analyses to determine if 
microenvironment or cell-intrinsic defects contributed to loss of rag expression and pre-B 
cells had not been conducted.  An advantage of using in vivo adoptive transfers to 
compare microenvironment and cell-intrinsic defects is that the cells analyzed are 
generated from earlier precursors while residing in the bone marrow microenvironment.  
In addition, samples were analyzed within hours after harvest, rather than after days in 
culture.  During culture, cells from young and aged mice may display defects that 
manifest themselves as cell-intrinsic defects but are actually established prior to harvest 
due to the in vivo microenvironment.  This would occur if precursor cells denied growth 
and developmental factors in vivo required had not been cleared by apoptosis.  During in 
vitro culture, these cells may not be able to recover from the lack of stimulus that was 
experienced in the animal, and may appear defective as they are already be destined for 
apoptosis. 
 
In this work, I conducted adoptive transfers of cells from young donor mice into 
young and aged mice and found that the aged bone marrow microenvironment was 
sufficient to result in reduced rag2 expression and numbers of pre-B cells (Chapter 2).  
The fact that bone marrow from young mice displayed reduced rag2 expression and 
V(D)J recombinase activity in pro-B cells and reduced numbers of pre-B cells in the aged 
host indicates that the defect responsible for these changes is dictated by the age of the 
microenvironment and not by cell intrinsic properties.  Interestingly, adoptive transfers of 
cells from young and aged mice into young recipient mice also indicated that the aged 
bone marrow microenvironment was the source of reduced rag2 expression and numbers 
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of pre-B cells (Chapter 2).  B cell precursors derived from bone marrow of young or aged 
mice had similar levels of rag2 expression and numbers of pre-B cells in young hosts.  In 
fact, the level of rag2 expression in pro-B cells from aged mice (that was lower in aged 
donor mice than in young donor mice) was restored to young-like levels following 
adoptive transfer into young host (Chapter 2).  Further support to indicate that 
microenvironment changes are responsible for the loss of pre-B cells is the finding that 
production rates of pre-B cells (as measured by BRDU labeling) are determined by the 
age of the adoptive host, rather than the marrow donor (Table 9) (Labrie et al. in 
preparation). 
 
4.7 Loss of pre-B cells may be due to reduced number or function of stromal cells. 
What is defective in the aged microenvironment that could result in reduced rag2 
expression and progression of pro-B cells in aged mice?  A leading candidate is a 
reduction in the function or number of bone marrow stromal cells.  B cell development is 
dependent upon both contact with and factors derived from bone marrow stromal cells.  
The stromal-derived factors IL-7, flt3L, SDF-1, and SCF are all either essential or 
strongly supportive for B cell development [as reviewed in (54)] and (46, 48, 53, 59).  
And while specific extrinsic factors that induce rag expression have yet to be identified, 
it remains possible that a reduction in the number or function of bone marrow stromal 
cells could reduce signals that regulate transcription factors and in turn, rag expression. It 
is also possible that the age-related decrease in rag2 expression could be due to 
attenuation of as yet unknown inductive signals that work independent of transcription 
factors. 
 
My observations of rag2-GFP expression (using NG transgenics) in aged mice are 
consistent with a reduction in numbers of stromal cells.  The percent of pro-B cells that 
express rag2 is reduced in aged mice, however, in pro-B cells that do express rag2, the 
average level of expression per cell is similar to that of young mice.  This is displayed in 
Figure 8 where the data obtained from analysis of pro-B cells from young and aged mice 
show that cells that are GFP+ have similar levels of expression per cell regardless of age.  
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This could indicate that fewer pro-B cells receive signals and factors from the stromal 
microenvironment, but those that do receive the required factors develop normally.  
Therefore, pro-B cell development may be limited due to access to reduced numbers of 
stromal cells and the short-lived, secreted factors that they produce.   
FIGURE 8. Per cell level of GFP expression in pro-B cells is similar in 
young and aged NG mice
Young
Aged
C
el
l 
n
u
m
b
er
GFP
Figure 8.  Per cell level of RAG2-GFP expression in pro-B cells is similar in 
young and aged NG mice.  Displayed are histograms of GFP expression in pro-
B cells harvested from representative young and aged NG mice.  Numbers 
above graphs represent the percent of pro-B cells that are GFP+, and the mean 
fluorescent intensity of GFP per cell.
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This hypothesis could be tested using cross-sectional immunohistochemical analyses 
of bone marrow from young and aged mice to determine if distribution of developing 
pro-B cells is reduced in bone marrow of aged mice.  Another method would be 
immunohistochemical analysis of bone marrow from young and aged rag2-GFP mice to 
determine if rag2 expression is restricted to fewer discrete areas in aged mice.  If rag2-
GFP mice were first crossed to rag2-/- mice to make rag2-/- rag2-GFP mice (that would 
therefore have no RAG2 protein), this would eliminate rag2-GFP expression in the bone 
marrow from B lineage cells past the pro-B cell stage.  It is possible to make these mice 
because the rag2-GFP transgene is located on a different chromosome than the 
endogenous rag locus thus enabling us to make a mouse that has rag2 knocked out at 
both loci and contains the RAG2-GFP transgene. [rag1 and rag2 are located on 
chromosome 2 and we have evidence that the rag2-GFP NG BAC is located on 
chromosome 8 (R. Gerstein data not shown)].  To avoid the time required to age these 
mice, bone marrow could be transferred from young rag2-/- rag2-GFP donors into young 
and aged recipients. 
 
4.8 Polymorphisms influence the frequency of pre-B cells and re-circulated B cells in 
the bone marrow of aged mice. 
One of goals of this research was to determine if the frequency of pre-B cells and 
other B cell subsets in the bone marrow of aged mice were influenced by genetic 
differences between inbred strains.  A QTL analysis of 18 month old UM-HET3 mice 
identified two simple sequence length polymorphisms (SSLPs) that appear to influence 
frequencies of B cell subsets in the bone marrow (Chapter 3).  My primary goal was to 
find a genomic marker corresponding to differences in frequencies of pre-B cells; this 
goal was accomplished. In addition, a marker associated with frequencies of re-circulated 
B cells was identified. 
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I found that the frequency of pre-B cells in the bone marrow is influenced by a 
specific SSLP, D19Mit41 on chromosome 19.  The polymorphism was determined to be 
between BALB/c and C57Bl/6 mice. The gene on chromosome 19 that influences the 
frequency of pre-B cells in aged bone marrow could be expressed in either B cell 
precursors or in stromal cells that provide essential support for B cell development.   
Stromal cells from aged mice are less supportive of B cell development than similar cells 
harvested from young mice (93, 94, 101) and we have found that the decline in pre-B cell 
frequency, rag2 expression and V(D)J recombinase activity in aged mice are all 
conferred by the aged bone marrow microenvironment (Chapter 2).  It is tempting to 
speculate that this genetic difference has an impact on developmental progression of pro-
B cells.  The genomic scan is not of sufficient resolution to identify specific polymorphic 
genes at this time:  however, it is exciting to note that BLNK (also known as SLP-65) is 
located on chromosome 19.  (BLNK is located within 15 Cm of the D19Mit41 marker.) 
BLNK is an adapter protein that couples signaling from the pre-BCR-associated Syk 
kinase with downstream pathways essential to progression of pro-B cells to the pre-B 
stage  (42).   It is possible that a polymorphic difference in either the BLNK coding 
sequence or in regulatory elements could result in reduced formation of the pre-BCR 
signaling complex and impaired pre-B cell generation.  Alternatively, the polymorphic 
gene could be in a different gene that is expressed in B cells or might be expressed in 
stromal cells that are required for B cell development.  
 
The frequency of mature re-circulated B cells in the bone marrow in the aged mouse 
cohort is influenced by a specific SSLP, D15Mit100 on chromosome 15 (Chapter 3).  Re-
circulating bone marrow B cells are mature B cells that resemble splenic follicular B cells 
and the B cells found in lymph nodes and peripheral blood.  These cells are presumably 
an important part of immune surveillance and decline of this population with aging might 
underlie or reflect compromised mature B cell function. It is tempting to speculate that 
this polymorphism could occur in a gene involved in B cell homing, either expressed in B 
cells or in the bone marrow microenvironment. 
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In the case of both polymorphisms (D15Mit100 and D19Mit41), the impact 
associated with the polymorphism could be age-dependent or age-independent.  In this 
study a QTL analysis was conduced on 18 month-old mice.  Bone marrow sampling is a 
terminal assay and as such samples were not obtained from the same cohort at a younger 
age.  Thus we cannot formally exclude the possibility that the phenotypic differences 
observed here might occur at any age.  Either scenario (age-dependent or age-
independent) is of interest to us. Age-independent genomic differences between mice 
could lead to identification of genes that regulate B cell development that are currently 
unknown.  Age-sensitive genomic differences have the potential to increase our 
understanding of mechanisms of immunosenesce in mice. 
 
Further mapping studies could be used to more accurately map the polymorphic 
differences associated with each trait.  Use of additional UM-HET3 mice would not be a 
practical approach; more refined mapping would require chromosomal cross-over events 
to determine precisely where on the chromosome the polymorphisms are located.  A 
more practical approach is the use of recombinant inbred mice.  The Jackson Laboratory 
offers 13 inbred strains of BALB/cBy X C57BL/6By recombinant inbred mice.  Table 10 
lists Strain Distribution Patterns for Chromosomes 15 and 19 in each of the 13 inbred 
strains recombinant strains.  Use of these mice would enable further mapping to the 
linkages of the SSLP to a smaller region of the chromosome, thus enabling candidate 
genes to be identified. 
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TABLE 10.  Recombinant Inbred Strain Distribution Patterns 
 
Chromosome 15 
CXB  strain   1    2    3    4   5    6   7    8    9   10  11  12  13 
D15Mit226    B   B   C   C   C   C   B   B   B    C   C   B   B 
D15Mit121    B   B   C   B   B   C   B   C   C    B   C   B   C 
D15Mit66    B   B   C   C   C   C   B   C   C    C   B   B   C 
Tgn    B   B   C   B   B   C   B     
Ly6     B   B* C   C* B* C* B* B   C   C    C   B   B 
Ly6d     B   B   C   C   B   C   B  
Pmv17     B   B   C   C   B   C   B  
D15Mit71    C   B   C   C   B   C   B   C   C   C   B   B   B 
Pdgf    B   C   B   C   C   B   C   B  
H30     B   B   C   C   B   C   B  
D15Mit159    B   C   C   C   B   C   B   B   C   C   B   B   B 
D15Mit34    B   C   C   C   B   C   B   B   C   C   B   B   B 
Gpd1    C* B   C   C   B   B   C  
Smar Cd1    C   B   C   C   B   B   C  
 
 
Chromosome: 19 
CXB  strain  1    2    3   4    5    6   7    8   9   10  11  12   13 
Mlviq2     B   B   B   B   B   B   B   C   B   C   B    B    B 
D19Mit59    C   B   B   B   B   B   B   C   B   C   B    B    C 
D19Mit109    C   B   B   B   B   B   B   C   B   C   B    B    C 
D19Mit61    C   B   B   C   B   B   B   C   B   C   C    B    C 
Ea4     C   B   B   C   B   B   B     
D19Mit23    C   B   B   C   B   B   B   C   B   C   C    B    C 
D19Mit41    C   B   B   C   B         B   C   B   C   C    B    C 
D19Mit85    C   B   B   C   B   B   B   C   B   C   C    B    C 
D19Mit46    C   B   B   B   B   C   C   B   C   C   C    C    B 
D19Mit40    C   B   B   B   B   B   B   B   B   B   C    B    B 
D19Mit19    C   B   B   B   B   C   C   B   C   C   C    B    B 
Cyp2 C29    C   B   B         B   C   C   B   C   C   C    B    B  
Iapls3-8    C   B   C   C   C   C   C   
D19Mit123    C   B   B   C   B   C   B   B   B   C   B    B    B 
D19Mit1    C   B   B   C   B   C   C   C   B   C   B    B    B 
D19Mit34    C   B   B   C   B   C   C   C   B   C   B    B  
Xmv18     C   B   B   C   B   B   C  
D19Mit6   C   B   B   C   B   B   C   B   B   C   C    B    B 
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TABLE 10.  Recombinant Inbred Strain Distribution Patterns.  Displayed are the 
marker maps for chromosomes 15 and 19 for the 13 strains of recombinant inbred 
BALB/cBy x C57BL/6By strains available from Jackson Labs.  *= inconsistent typing, 
and blank spaces are untyped.  Table was replicated from http://www.informatics.jax.org. 
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4.9 Frequencies of peripheral T cell subsets are not correlated with loss of pre-B 
cells in aged mice. 
Another important age-related change in the immune system is thymic involution, 
which begins shortly after adolescence.  While B cell development is generally regarded 
as independent of T cells, pre-B cell numbers are lower in athymic mice than in age-
matched controls and are partially restored following transfer of syngeneic T cells (97-
99).  In addition, numbers of pre-B cells are increased in aged and athymic mice 
following injection of either supernatant harvested from cultures of CD8 T cells activated 
in vitro or rIL-16 (97-99).  These observations support the concept that reduced thymic 
output of T cells or altered peripheral T cell populations could contribute to lower pre-B 
cell numbers in aged mice.  If this idea is correct, mice with more profound age-related 
alterations in T cell subsets or activation might be expected to suffer greater impairment 
of B cell development.  We compared frequencies of peripheral T cells subsets known to 
be altered in aged mice   (CD4M, CD8M, CD4P and CD8P in blood and spleen) and 
activation of splenic T cells following in vitro stimulation with anti-CD3 (Chapter 3). We 
found no correlation between the frequencies pre-B cells in the bone marrow and either 
the frequencies of T cell subsets or the extent of proliferation of splenic T cells.  This lack 
of correlation suggests that the age-associated reduction in pre-B cells occur independent 
of alterations in T cell subsets in aged mice. 
 
4.10 Frequency of re-circulated B cells is not correlated with loss of pre-B cells in 
aged mice. 
In addition to a decline in the number of pre-B cells in aged mice, there is also an 
increase in the number of mature re-circulated B cells in the bone marrow (9, 91, 132).  
The requirements for homing, survival and persistence of mature B cells in the bone 
marrow are not well understood.  It is possible that the increased number of re-circulated 
B cells in the bone marrow competes with developing precursors, therefore resulting in 
attenuated B cell development.  If this were true, we would expect there to be an inverse 
correlation between frequencies of pre-B cells and re-circulated B cells in the bone 
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marrow.  However, we did not observe an inverse correlation between re-circulated B 
cells and pre-B cell frequencies in the UM-HET3 aged cohort (Chapter 3).  This could 
indicate that mature B cells do not inhibit earlier stages of B cell development or that this 
effect is not seen as early as 18 months of age.  Analysis of pre-B cells and re-circulated 
B cells in bone marrow in inbred strains of mice indicate that the “aged phenotype” 
occurs more frequently in mice older than 18 months of age. 
 
4.11 Frequencies of B220LOIgM+ cells are inversely correlated with frequencies of 
pre-B cells in aged mice.  
We did not observe correlations between the frequency of pro- and pre-B cells with 
those of peripheral T cell subsets or re-circulated B cells in the UM-HET3 cohort.  
However, we did find that frequencies of both pro and pre-B cells were inversely 
correlated with the frequency of B220intIgM+ cells in the bone marrow (Chapter 3).  Mice 
with higher numbers of B220intIgM+ cells tended to have fewer pro- and pre-B cells. 
Interestingly, the frequency of B220intIgM+ cells in the bone marrow was greater in mice 
that had more extensive age-associated changes in T cell subsets (higher frequencies of 
CD4M, CD8M in both blood and spleen and higher CD4P in spleen, and CD8P in blood).   
 
These B220intIgM+ cells could be pre-memory plasma cells that have homed to the 
bone marrow. Further studies would be needed to evaluate whether these cells were 
elicited in response to the immunization at 15 months with turkey RBC.  The mice were 
housed in SPF conditions and quarterly serology testing of sentinel mice found no 
evidence for viral infection during the course of these experiments, but we cannot 
completely exclude that increased B220intIgM+ cells could result from encounter with 
other infectious agents or environmental antigens of unknown kinds.  These cells might 
also be activated autoimmune B cells.  There is an increase in low affinity auto-reactive 
antibodies in aged mice (2, 3, 144, 145).  It is possible that advanced T cell decline with 
age leads to a reduction in tolerance to self-antigens, resulting in an increase in activated 
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autoimmune B cells. The relationship of increased frequency of B220intIgM+ cells in the 
bone marrow and autoimmunity deserves further study. 
 
4.12 Aging and B cell development in humans 
Observations of aging defects in human B cell development are limited and 
conflicting. 
Nunez et al. observed that the frequency of bone marrow surface -CD24+ cells 
(combined pro- and pre-B cells) decreases with age (fetus through 80 years old), and is 
greatly reduced at all ages compared to that of a fetus.  However, this analysis included 
only 22 individuals, variability was high, and results of statistical analyses were not 
included (151).  Nunez et al. also found expression of rag1, rag2 and TdT in bone 
marrow pro-B cells (CD34+CD19+) from one fetus, four individuals 28 to 37 years of 
age, and one 62 year old individual (151).  Expression of rag1, rag2 and TdT were 
comparable in pro-B cells from fetal bone marrow and that of the 62 year old (151).  This 
observation could indicate that rag expression is retained in aged humans; however, to 
my knowledge a quantitative comparison of rag expression in young (post-birth) and 
aged humans has not been conducted and the detection of rag expression in a single 62 
year old individual may not be representative.  McKenna et al.  noted a significant 
decline in frequency of bone marrow B cell precursors (combined percent of pro-, pre-, 
and immature B cells) with age (n= 432, r= -0.35, p< 0.001). Variation was high between 
individuals of similar ages.  Some adults, including those of advanced age, had a 
relatively high frequency of B cell precursors.  Recently, Rossi et al. (152) determined 
that frequencies of B cell precursors do not change with age (ages 24 to 88 years).  When 
frequencies of pro-, pre-, immature, naïve and mature B cells in the bone marrow were 
determined, differences between age groups were not statistically significant. However, 
variation between individuals was high, and number of individuals (total and within each 
age group) was not reported. 
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Additional work is required to determine if B cell development is diminished in aged 
humans.  In the three studies mentioned above, the frequencies of B cell precursors are 
compared, rather than absolute cell numbers (which are very difficult to measure in 
human bone marrow).  In addition, in these and most human studies, there are 
considerable genetic and environmental differences between individuals, and therefore 
changes in the number of B cell precursors as a result of age-related defects could be hard 
to detect.  In each of the papers discussed above, the variability between individuals are 
high, and number of individuals are limited in one paper (151) or not stated in another 
(152).  In these studies, it is possible that statistically significant differences between 
groups would not be observed unless the differences are of great magnitude.  In the study 
with a large number of individuals, a significant decrease in combined pro-, pre- and 
immature B cells with age was observed (153).  Therefore, it remains possible that age-
related changes in human B cell development occur, and that they are more subtle than 
those of  mice but still have significant impact on adaptive immunity.   Alternatively, it 
may be true, as indicated in Rossi et al. that B cell development is not attenuated in aged 
humans (152). 
 
Understanding age-associated changes in mice is still valuable as a model of aging, 
even if B cell progenitor frequencies are not reduced in humans.  Stable frequencies of B 
cell precursors in aged humans do not rule out other age-associated defects.  It is possible 
that Ig diversity is reduced in aged humans, if, in humans, rag expression decreases in 
pro-B cells (as I found in murine pro-B cells; Chapter 2).  Despite the lack of observed 
defects in B cell development with age, B cell-mediated immunity is still greatly 
impaired in aged humans, as shown by decreased antibody response to vaccines and 
increased mortality to infection (2).  Some of this impairment can be attributed to 
decreased T cell help (as discussed in the Introduction) but reduced diversity of B cell 
receptors could contribute as well.  In addition, the three studies noted above found 
extensive variability in the frequency of B cell precursors between humans of similar 
advanced ages.  It would be valuable to determine if lower frequencies of B cell 
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precursors are observed in individuals with reduced antibody response to vaccines and 
increased frequency of infections.  This hypothesis could also be tested in aged mice.  In 
addition, the use of mice could lead to the identification of genes that regulate age-
associated defects in B cell development (such as those linked to the polymorphs found in 
our analyses [Chapter 3]).  Polymorphic differences in the corresponding genes in 
humans may lead to therapeutics that enhance B cell development in aged humans or 
humans with other conditions that attenuate B cell development such as HIV, post-
chemotherapy, post-bone marrow transplant, lymphomas and multiple myeloma (93, 
153). 
 
4.13 Summary and future goals 
Here I have shown that expression of rag2 and V(D)J recombinase activity are 
reduced in pro-B cells of aged mice and are correlated with the loss of pre-B cells.  These 
defects are a result of the aged bone marrow microenvironment.  In addition, pre-B cell 
frequencies in aged mice are influenced by a polymorphic difference between C57BL/6J 
and BALB/cJ mice.  Furthermore, the percent of pre-B cells in aged mice is inversely 
related to the frequency of B220intIgM+ cells in the bone marrow and not correlated with 
frequencies of re-circulated B cells or peripheral T cell subsets. 
 
While this work has provided several contributions to our understanding the effect of 
aging on B cell development, there are numerous issues that remain to be resolved.  This 
includes determining if stromal cell numbers or functions are reduced in aged mice and 
further mapping of the polymorphisms located on chromosomes 15 and 19.  Other future 
efforts might involve determining if the defect if rag2 expression and V(D)J recombinase 
activity in aged mice is related in cause to another defect in gene expression in pro-B 
cells of aged mice.  5 and E2A gene products (E12 and E47) are reduced in pro-B cells 
of aged mice (91, 95, 100).  It is possible that reduced expression of these B cell specific 
proteins are due to the same mechanism that results in loss of rag2 expression and V(D)J 
recombinase activity.  It would be valuable to next determine if reduced expression of 5 
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and E2A are observed in all pro-B cells or if the reduction in expression is attributed to a 
reduced percent of pro-B cells that express these genes.  Additionally it would be 
interesting to determine if E2A, 5, and rag2 expression occur in the same pro-B cells in 
aged mice, while other pro-B cells are devoid of expression of all three genes.  Both of 
these questions could be tested by sorting GFP+ and GFP- pro-B cells from aged rag2-
GFP mice (or aged wild type mice that have received adoptive transfers of bone marrow 
from rag2-GFP mice) and conducting RT-PCR or western blots for 5, E12 and E47 
expression or proteins. 
 
Therefore, better understanding of the underlying mechanisms responsible for these 
defects in B cell development in mice should enable the design of experiments to address 
these changes in humans.  Ultimately, this could lead to therapeutics that restore B cell 
production and improve the adaptive immune response to both pathogens and vaccines in 
aged humans. 
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